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SUMMARY
This thesis covers two main topics of research: (1) the use of 1- 
pyrroline and 1-piperideine aimed towards the synthesis of alkaloids 
and analogues; and (2) the inhibition of diamine oxidase.
(1) The Use of 1-Pyrroline and 1-Piperideine aimed towards 
the Synthesis of Alkaloids and Analogues.
1-Pyrroline is an unstable oil but can be complexed with zinc 
iodide to form a stable solid. This complex can be reacted, as a source 
of 1-pyrroline, with a range of p-ketoacids to give acylpyrrolidines in 
high yield. 1-Pyrroline was also found to form stable solid complexes 
with zinc chloride, zinc bromide and cadmium iodide. Attempts to use 
the zinc iodide complex as a source of 1-pyrroline in cycloaddition 
reactions proved unsuccessful. The complexation of 1-piperideine 
with zinc iodide also proved unsuccessful, though 1-piperideine was 
reacted with p-ketoacids to form acylpiperidines. 1-Piperideine and 
piperidine have been used in the construction of quinolizidine and 
tetracyclic quinolizidine alkaloids.
(2) The Inhibition of Diamine Oxidase.
A range of cyclic diamines was synthesised and tested as 
inhibitors of diamine oxidase using a spectrophotometric assay. This 
is a peroxidase-coupled assay which monitors the production of 
hydrogen peroxide during diamine oxidation. Although many of the 
compounds synthesised lack a primary amino group they are 
substrate analogues and could bind well to the enzyme. The majority
of the compounds synthesised, inhibited the diamine oxidase catalysed 
oxidation of cadaverine, and they were shown to be competitive 
inhibitors. A range of K[ values was obtained for the compounds 
tested.
CHAPTER 1
REVIEW OF CYCLIC IMINES IN ORGANIC SYNTHESIS
1.1 The Importance Of Imines______
The use of imines and enamines in organic synthesis has been 
well documented. E2 The electrophilic nature of the carbon atom of 
the imine provides a ready site for nucleophilic attack. Most of the 
work in imine chemistry has focused on finding limits of chemical 
reactivity and structure of imines, but the applications to specific 
synthetic goals has established the use of imines in organic chemistry.
Imines also have an important role in the biosynthesis of a wide 
range of natural products. For example, 3,4-dihydro-2//-pyrrole (1- 
pyrroline) (1) has proved of interest to chemists for many years due 
to its proposed role in the biosynthesis of phenanthroindolizidine 
alkaloids such as septicine (2) and tylophorine (3).3
N
(1) (4)
l
CH
OCHOCH
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1.2 Synthesis of Cyclic [mines
Generally, the use of these reactive compounds in organic 
synthesis has suffered from the limitations present in the methods of 
generation of the iminium ion intermediates. These include low yields 
and lack of regiospecificity.4
Cyclic imines such as 1-pyrroline (1) and 3,4,5,6-
tetrahydropyridine (1-piperideine) (4) are potentially very useful 
synthetic imines, but their use has been hampered by their lack of 
stability and tendency to polymerise. Schopf carried out some of the 
earliest work on the preparation of 1-pyrroline.5 Schopf developed 
one method which involved the hydrolysis of 4-aminobutanal diethyl 
acetal (5) at pH 5 which generated the imine in  situ which was further 
condensed with ortho-aminobenzaldehyde (Scheme l . l ) . 5 1-Pyrroline 
can also be generated from ornithine (6) following treatment with N- 
bromosuccinimide 6 (Scheme 1.2) and by dehydrohalogenation of N- 
chloropyrrolidine (7) (Scheme 1.3).7
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The apparently simple procedures of partial dehydrogenation of 
pyrrolidines and partial hydrogenation of pyrroles do produce 1- 
pyrroline, however, the reactions are complex and of little preparative 
value.7 A better method involving an enzyme is also available. The 
action of pea-seedling diamine oxidase on 1,4-diaminobutane 
(putrescine) (8) and 1,5-diaminopentane (cadaverine) (9) produces, 
respectively, 1-pyrroline and 1-piperideine.8 This is discussed in 
more detail later.
H2N(CH2)4NH2 H 2N ( C H 2)5NH2
(8) (9)
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Rapoport and co-workers developed a method of generating 
cyclic iminium salts in high yields.9 Generation of the iminium ion 
was achieved by decarbonylation of readily available a- 
(tertiaryamino)acids. The acids were mixed with an excess of 
phosphorus oxychloride and heated briefly to complete 
decarbonylation. Proline, pipecolic acid and hexahydroazepine-2- 
carboxylic acid served as the starting materials for the synthesis of 
pyrrolizidines, indolizidines, quinolizidines and 1- 
azabicyclo[5.4.0.]undecanes. One example of this synthetic strategy is 
the formation of diethyl l-azabicyclo[4.4.0]decane-5,5-dicarboxylate 
(10) which is shown in Scheme 1.4. Pipecolic acid (11) was converted 
into the a-amino acid benzyl ester (12) which was then alkylated with 
diethyl 3-bromopropylmalonate (13) to give the triester (14). The 
benzyl group was removed by hydrogenation to give the free amino 
acid (15) as a crystalline solid. To effect cyclisation, the amino acid 
was treated with phosphorus oxychloride and heated to form the 
iminium ion. The mixture was then quenched with water and the pH 
adjusted to 6-6.5 which resulted in cyclisation to the corresponding 1- 
azabicycloalkane diester (10).
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A more recent approach to the synthesis of 1-pyrrolines has 
been developed by Zard and co-workers (Scheme 1.5).10 A range of 
sulphenylimines (16) containing a double bond y,f> to an imine were 
treated with tri-n-butylstannane to produce the corresponding 1- 
pyrroline derivatives (17) in good yield. Sulphenylimines are 
accessible from the corresponding carbonyl derivative or, in some 
cases, from the oxime.
(16)
Bu3Sn*
(17) 
Scheme 1.510
H SnBu
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1.3 Cyclic Imines in Alkaloid Synthesis
The earliest uses of cyclic imines in natural product synthesis 
were electrophilic reactions with the iminium salts and a number of 
syntheses are based on the reaction of these iminium salts with 
reactive methylene compounds under physiological conditions.
The reaction between 2-oxo-N-methylpyrrolidine (18) and 
lithium aluminium hydride, shown in Scheme 1.6, produces the 
corresponding iminium ion which combines with one equivalent of 
acetonedicarboxylic acid to give hygrine (19)11 or 0.5 equivalents of 
acetonedicarboxylic acid to give cuscohygrine (20).12
Tamelen and Foltz reported a synthesis of lupinine (21) and its 
epimer (22) using a Mannich-type cyclisation of a malonate derivative 
involving an iminium ion intermediate (23) (Scheme 1.7).13 N-(4,4- 
Dicarbethoxybutyl)piperidine (24) was obtained by the reaction of 
diethyl 3-bromopropylmalonate (13) with 2 equivalents of piperidine 
in benzene. Mercuric acetate dehydrogenation of (24) yielded 1,1- 
dicarbethoxyquinolizidine (26). Treatment of this product with 
hydrochloric acid to affect hydrolysis and decarboxylation followed by 
reduction with lithium aluminium hydride afforded the mixture of 
epimers (21) and (22) in a ratio of 1:1.
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As previously mentioned 1-pyrroline (1) has been proposed as 
an intermediate in the biosynthesis of alkaloids such as septicine (2) 
and tylophorine (3). The use of an enzymic method to generate 1- 
pyrroline and 1-piperideine in the synthesis of these alkaloids has 
been employed by Herbert and co-workers. H 1 5  They approached the 
synthesis of these compounds by a biogenetically patterned sequence, 
as shown in Scheme 1.8. 1-Pyrroline was prepared in  situ by the
oxidation of putrescine (8) using partially purified diamine oxidase 
and condensed with (3,4-dimethoxybenzoyl)acetic acid (27). 
Condensation of the product (28) with 3,4- 
dimethoxyphenylacetaldehyde (29) in benzene produced the enamine 
intermediate (30) which then underwent intramolecular cyclisation 
and dehydration. Reduction with sodium borohydride yielded 
septicine (2) which, on oxidation with thallium(III) trifluoroacetate, 
produced tylophorine (3).
A similar reaction sequence using 1-piperideine, generated in  
situ from cadaverine using pea seedling diamine oxidase, resulted in 
the synthesis of 3',4,-dimethoxy-2-(2-piperidyl)acetophenone (31), 
julandine (32) and cryptopleurine (33).
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Syncarpurea (34), a minor metabolite of Uvaria afzelii, has 
shown interesting antibiotic and antitumour properties.16 Clardy and 
Okamoto have reported two relatively simple syntheses of this natural 
product17 The first approach, shown in Scheme 1.9, involved the 
generation of 1-pyrroline from the reaction between ornithine 
hydrochloride and N-bromosuccinimide. The imine was then reacted 
with syncarpic acid (35), prepared from 2,4,6- 
trihydroxy acetophenone, to give (36). This product was then heated 
with urea (37) to produce syncarpurea (34). In the second approach 
to the synthesis, citrulline was treated with N*bromosuccinimide to 
yield the l-carboxamido-Ai-pyrrolidinium (38) ion in  situ. Further 
reaction with syncarpic acid produced syncarpurea (34) in good yield 
(Scheme 1.10).
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1.4 Imines In Diels-Alder Cvcloadditions
The Diels-Alder reaction is undoubtedly one of the most useful 
methods for the construction of carbocyclic systems. Alder wrote a 
brief description of the first example of a [4+2] cycloaddition reaction 
with an imine as the dienophile in a review in 1943.18 The reaction 
between the enamine (39) and a number of dienes did not produce 
the expected carbocyclic systems. Instead the reaction proceeded by 
means of the imine tautomer (40) as the reactive species to produce a 
range of tetrahydropyridines (41) (Scheme 1.11). It has therefore 
been known for decades that reactive species can be generated, in 
which one or both of the atoms of the dienophile have been replaced 
by heteroatoms. There have been many reviews since, on the use of 
imines as dienophiles 19,20,21
Generally, free imines make poor dienophiles, but do take part 
in Diels-Alder reactions in the presence of a Lewis acid catalyst.22 
Electron deficient imines have particularly proved to be the most 
effective dienophiles. Simple Schiff bases have been shown to be 
unreactive in [4+2] cycloadditions unless exceptionally reactive dienes 
are employed. 23>24 The generality of the Diels-Alder reaction with 
electron deficient species was highlighted by work using ^acylimines 
and their iminium salts25 and N-sulfonylimines.26 JV-Acylimines are 
good electrophiles27 and can also react as dienes in Diels-Alder 
cycloadditions28 and j'fsulfonylimines make good enophiles.29 
However, the scope of these reactions are limited since both types of 
imines are rapidly hydrolysed in the presence of traces of water.
14
NHPh
(39) (4° )
Y
PhN.
Scheme 1 .1118
Weinreb has reported the synthesis of a number of alkaloids by 
intramolecular imino Diels-Alder cycloadditions.30 In a different 
approach to the synthesis of tylophorine (3), shown in Scheme 2.12, 
Weinreb heated the acetate (42) in a sealed tube to give the 
pentacyclic lactam (43). The N-acylimine intermediate (44) undergoes 
a [4+2] cycloaddition to afford (45) followed by a 1,3-hydrogen shift to 
produce (43). Reduction of (43) with lithium aluminium hydride gave 
tylophorine (3).
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Weinreb also investigated the application of the intramolecular 
imino Diels-Alder reaction to the synthesis of epilupinine (22) 
(Scheme 1.13 ). 30 The acetate (46) was prepared from methyl sorbate 
and heated to reflux in odichlorobenzene. The product formed was 
one epimer only of the bicyclic lactam. Catalytic hydrogenation of this 
epimer, followed by borane reduction yielded racemic epilupinine 
(22). It was thought that unfavourable interactions between Ha/Hb
16
and Hc/Hd in the intermediate (47) could account for the absence of 
the second lactam (48).
PhCH?0
->■
-HOAc
(22)
-HOAc PhAcO
(46)
(47) (48)
Scheme 1.1330
1.5 Natural Product Biosynthesis Involving Iminium Ions
It was first suggested in 1955 that the biosynthetic pathways to 
the pyrrolizidine alkaloids isoretronecanol (49) and retronecine (50), 
and the quinolizidine alkaloid lupinine (21), could be very similar 31 
It was suggested that isoretronecanol was derived from two molecules 
of ornithine (6), and lupinine from two molecules of lysine (51). 
However, with the advent of highfield NMR spectroscopy for isotopic 
labelling studies this theory has been proven incorrect and the 
pathways are in fact quite different.
17
1.5a The Biosynthesis o f Retronecine
The biosynthesis of retronecine involves a symmetrical 
intermediate formed from two molecules of putrescine (8) as shown in 
Scheme 1.14.32 The putrescine is derived from either L-arginine33 
(52) or L-ornithine (6).34«35 Oxidation of putrescine, catalysed by 
homospermidine synthase, produces an enzyme-bound intermediate 
which reacts with a second molecule of putrescine. The resulting 
imine is reduced by NADH to give homospermidine (53).36 Oxidation 
of a primary amino group of (53) yields the iminium ion (54)37 which 
is converted into (55) by oxidative deamination of the other primary 
amino group. There are two possible cyclisations of the iminium ion. 
Following reduction of the aldehydes an endo-alcohol or an exo­
alcohol are formed.38 The exo-alcohol, trachelanthamidine (56), is the 
likely precursor of retronecine39 and heliotridine (57), and otonecine 
(58) is probably formed from retronecine. The endoalcohol, 
isoretronecanol, is converted by two hydroxylations into 
rosmarinecine (59).
1.5b The Biosynthesis of Lupinine
As mentioned earlier it was proposed that lupinine (21) is 
derived from two molecules of lysine. By analogy with the proposed 
pathway to isoretronecanol this would suggest that the route to 
lupinine would proceed via cadaverine (9). L-Lysine and cadaverine 
have both been shown to be precursors of lupinine.40 However 
evidence from feeding [^C-ISN] labelled cadaverine indicates that 
there is no later symmetrical intermediate in the lupinine pathway, in 
contrast to the biosynthesis of retronecine.41
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It has been proposed that two molecules of 1-piperideine are 
generated from cadaverine which may combine to form 
tetrahydroanabasine.42 The proposed pathway to lupinine is shown in 
Scheme 1.15
NH
NH
(9)
CHO
NH2 NHNH
CHO
NH
/
CHO
NH
NH
NH
/
Scheme 1.15
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1.5c The Biosynthesis o f T e tracyc lic  Q u in o liz id in e  A lka lo ids
Labelling studies have indicated that tetracyclic quinolizidine 
alkaloids such as (-)-sparteine (60) and (+)-lupanine (61) are derived 
from three molecules of lysine and cadaverine."13 Golebiewski and 
Spenser suggested the cadaverine is oxidized to S-aminopentanal 
which is in equilibrium with 1-piperideine. It was thought that the 
alkaloids are formed from a modified form of the trimer of 1- 
piperideine.44 Later evidence then suggested that
tetrahydroanabasine was involved as an intermediate and the 
tetracyclic system is formed by combination with a third five carbon 
unit.45 However, no intermediates between cadaverine and tetracyclic 
quinolizidine alkaloids have been firmly established. The proposed 
pathway to (-)-sparteine from tripiperideine is shown in Scheme 1.16. 
One of the intermediates postulated in this pathway is the bis- 
(iminium) ion (62 ).45 Sparteine and lupanine could both be formed by 
stereospecific attack of a hydride donor on these iminium ions.
The synthesis of the tetracyclic quinolizidine alkaloid 8- 
ketosparteine is discussed in Chapter 2.
vo
(61) (62)
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CHAPTER 2
THE USE OF 1 -PYRROLINE AND 1-PIPERIDEINE IN 
ALKALOID SYNTHESIS
2.1 Introduction_____
The generation and the use of imines in organic synthesis, 
and their role in natural product biosynthesis was discussed in 
detail in Chapter 1. In this chapter the following topics will be 
covered: the synthesis and stabilisation of 1-pyrroline (1) as a 
complex with a variety of metal halides; the use of 1-pyrroline 
complexes in alkaloid synthesis and cycloaddition reactions; and 
finally the synthesis and use of 1-piperideine (4) in alkaloid 
synthesis and cycloaddition reactions.
2.2 Synthesis o f 1-Pvrroline Complexes
As previously mentioned, 1-pyrroline is a useful sython for 
the construction of 5-membered systems, but its usage is limited 
due to its instability and tendency to trimerise to (63) in basic 
solution.7^  The work of Schopf revealed that the acidic 
hydrolysis of 4-aminobutanal diethylacetal (5) does not yield the 
free aldehyde, instead it produces 1-pyrroline which is stable up 
to 100 °C in acid.5
23
VJ
(63)
It was recently discovered at the end of a Ph.D. project by 
George Baxter47 that 1-pyrroline forms a stable crystalline 
complex with zinc iodide. The discovery was made while 
attempting to react a solution of 1-pyrroline in ether with 
cydopentadiene (64) using zinc iodide as a Lewis acid catalyst as a 
route to 1,3-disubstituted pyrrolizidines (65) (Scheme 2.1).
Scheme 2 .147
Instead of the desired product a white solid was obtained 
with the empirical formula C8Hi4N2l 2Zn which suggests a 
molecular formula of (C4H7N)2Znl2 which was assigned the 
tetrahedral structure (66) from knowledge of other zinc 
complexes. Compared to the free imine, all the signals in the 1H 
NMR spectrum were shifted downfield as a result of the electron 
withdrawing effect of the zinc. The infra-red spectrum shows the 
imine stretch at 1635 cm-1 compared to 1620 cm”1 for the free
(1) (64) (65)
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imine. Also present in the infra-red spectrum is a zinc-iodine 
stretch at 420 cm-1.
N}
,  Zn
O
(66)
It was our aim to synthesise the complex and obtain good 
crystals in order to obtain confirmation of the structure by X-ray 
crystallography. It was also of interest to investigate whether the 
reaction of 1-pyrroline with zinc iodide is unique or if other metal 
halides yield similar complexes.
4-Aminobutanal diethylacetal (5) underwent acid hydrolysis 
at 0 °C in ether. On treatment with base, 1-pyrroline could be 
extracted with cold ether. Addition of zinc iodide to ethereal 
extracts at 0 °C precipitated the complex and recrystallisation 
from chloroform gave the complex in 61% yield. Cold ether is 
used in the work-up since 1-pyrroline is very volatile.
Structure (66) was confirmed for the complex by X-ray 
crystal structure analysis, shown in Figure 2.1. This was carried 
out by Dr. A. A. Freer in the University of Glasgow. The molecule 
straddles a mirror plane with the zinc atom sitting on the plane. 
One of the 1-pyrroline rings lies in the mirror plane and the other 
lies perpendicular to it.-48
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Figure 2.3
1-Pyrroiine was also found to react with zinc chloride, zinc 
bromide and cadmium iodide to give compounds (67)-(69) 
(Scheme 2.2) Both the zinc chloride and zinc bromide complexes 
gave elemental analyses similar to the zinc iodide complex. 
However the cadmium iodide complex gave an elemental analysis 
indicating an empirical formula of QHyNIzCd. These three 
additional complexes were formed in rather lower yields 
compared to the zinc iodide complex. For that reason, combined 
with the possibly high toxicity of the cadmium complex, the zinc 
iodide complex was used as the starting material for the following 
syntheses.
Zna2(C4H7N)2
(67)
ZnBr2(C4H7N)2
(68)
CdI2(C4H7N)
(69)
2.3 The Use of the Complex with B-Ketoacids
George Baxter investigated the ease with which 1-pyrroline 
could be released from the complex. He found that the free imine 
could be obtained using ethylene diamine, diethylamine, 
ammonia, ethylamine or triethylamine, by displacement of 1- 
pyrroline as the ligand. The use of the complex as a direct source 
of 1-pyrroline was also investigated. As mentioned in Chapter 1
ON‘
(1)
Znd2
ZnBr2
Cdl2
■>-
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Herbert and co-workers generated 1-pyrroline from putrescine 
enzymically for the synthesis of phenanthroindolizidine 
alkaloids. H15 George Baxter used the complex directly and added 
it to a solution of acetoacetic acid and phosphate buffer in 
methanol to give norhygrine (70) (Scheme 2.3).
COMPLEX
(66)
MeOH (aq)
pH 7 
— - —
rt. 48h.
+ CH3G0CH2CD2H
GOCH
NH
(70)
Scheme 2.347
In our work, we repeated this synthesis of norhygrine and 
adapted it to the synthesis of ruspolinone (71). Ruspolinone is a 
pyrrolidine alkaloid isolated from Ruspolia hypercrateriform is  a 
plant of the Acanthaceae family.^ The zinc iodide complex in 
methanol was added directly to 3,4-dimethoxybenzoylacetic acid 
(72) in phosphate buffer. After 48 hours reaction time, 
ruspolinone was isolated in 92% yield (Scheme 2.4). Preparative 
TLC gave the purified product in 81% yield. The IR spectrum 
showed the ketone carbonyl absorption at 1675 cm*1 and high 
resolution mass spectrometry gave a molecular weight of 
249.1356 in accordance with a theoretical value of 249.1365. The 
!H and 13c NMR spectra were both in accordance with literature
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spectra of ruspolinone.50 This work on the preparation and use of 
the zinc complex has been published.51
COMPLEX +
CH3 GOCH2CD2H MeOH (aq) 
 P-H.7^
(66) rt. 48h.
COAr
(71)
Scheme 2.4
3,4-Dimethoxy benzoyl acetic acid (72) is not available 
commercially and was synthesised as shown in Scheme 2.5.52 3,4- 
Dimethoxybenzoyl chloride (73) was prepared from the acid (74) 
by stirring with excess thionyl chloride. The thionyl chloride was 
removed by evaporation and the acid chloride was used 
immediately in the next stage without purification. The reaction 
of the acid chloride, ethyl acetoacetate and sodium gave the 
product, ethyl 3,4-dimethoxybenzoylacetoacetate (75) in 86% 
yield. Removal of the acetyl group using a catalytic amount of 
sodium acetate yielded ethyl 3,4-dimethoxybenzoylacetate (76). 
Base hydrolysis of the p-keto ester yielded the p-keto acid (72). 
The acid decarboxylates readily above 25 °C, so the hydrolysis 
stage was not carried out until 2 days before the acid was 
required and it was then stored in the freezer.
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SOd:
Sodium acetate/ 
aq.EtOH
(D2CH2CH3
aq. KOH
Scheme 2.5s2
Ethyl acetoacetate/ 
Sodium/
V THF
O
OOCHj
CH
(75)
CD2H
(72)
2.4 Diels-Alder Reactions of the 1-Pvrroline Complex
The next stage in our work was to investigate the use of the 
complex as a source of 1-pyrroline for cycloaddition reactions. As 
mentioned in Chapter 1, free imines are poor dienophiles, but in 
the presence of a Lewis acid catalyst will take part in Diels-Alder 
cycloaddition reactions. It was hoped that the zinc iodide present
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in the complex would provide a source of this catalysis. The 
reaction of the complex with the trimethylsilyl ether of methyl 
vinyl ketone has already been unsuccessfully tested under a 
variety of reaction conditions.47 In our work a range of dienes 
was used in reaction with the complex and the results are shown 
in Table 2.1.
Diene Solvent Conditions Temp Time Result
2,3-Dimethyl- neat sealed tube 150°C 18h tar
1,3-butadiene DMF under N2 RT 18h trimer
h 2o open RT 18h trimer
h 2o open o°c 18h trimer
Methyl 2,4-hex- neat sealed tube 140°C 24h tar
adienoate (77) DMF under N2 RT 24h trimer
Methyl 2,4-pen- neat sealed tube 150°C 24h tar
tadienoate (78) DMF under N2 RT 24h trimer
l-Acetoxy-1,3- neat sealed tube 70°C 24h tar
butadiene 
Table 2.1
No success was achieved with the complex despite the 
variety of reaction conditions tested. It is possible that the 
complex is simply unsuitable as a source of 1-pyrroline for these 
types of reactions.
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The next logical step in this work was the consideration of 
1-piperideine (4) in complexation with zinc iodide and comparison 
of its behaviour to 1-pyrroline in parallel experiments leading to 
heterocyclic compounds of biological interest.
2.5 Synthesis o f 1-Pioerideine
The formation of 1-piperideine from a number of starting 
materials was investigated.
1-Piperideine can be easily prepared in a convenient one 
step reaction from lysine (51) (Scheme 2.6).53 An aqueous 
solution of L-lysine monohydrochloride was treated with N- 
bromosuccinimide. The hydrogen bromide formed was removed 
by evaporation and addition of base to the aqueous solution 
allowed extraction of the free imine into cold ether, Addition of 
zinc iodide to the ethereal extracts failed to precipitate the desired 
product. In the absence of zinc iodide the organic extracts were 
evaporated to give a clear oil. The lH NMR spectrum of the 
product indicated that 1-piperideine was the major component, 
though traces of unreacted lysine and succinimide were present.
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oooh 1. NBS., 45°C
H2N NH3+C1' 2. K2(D3 •N '
(4)
\ /
/ s
COMPLEX
(66)
Scheme 2.6
Like 1-pyrroline, 1-piperideine is known to trimerise in 
basic solution.5^  This tripiperideine (79) can be 'cracked' in acid 
as an efficient route to the monomer imine. Tripiperideine was 
prepared by the treatment of piperidine (25) with N- 
chlorosuccinimide to form N-chloropiperidine. Addition of 
potassium hydroxide in ethanol to the mixture effects 
dehydrohalogenation to give tripiperideine (79) in 71% yield, 
following recrystallisation. 115 Treatment of the trimer with 
concentrated hydrochloric acid, followed by adjustment of the pH 
to 9 allowed the extraction of 1-piperideine into cold ether. 
Addition of zinc iodide to the extracts failed to precipitate the 
desired product (Scheme 2.7).
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N
H
(25)
1. NCS, Et20
2. KOH , EtOH ,70 C
(79)
2. NH3
Scheme 2.7
1. c.HCl, -25VC Znl2
COMPLEX
(66)
At this stage it seemed unlikely that 1-piperideine formed a 
complex with zinc iodide. It was decided therefore to find a route 
to 1-piperideine which might be extended to the corresponding 7- 
membered ring compound and its zinc complex.
The reaction of piperidine, triethylamine and N- 
bromosuccinimide in dichloromethane gave a mixture of products 
by TLC (Scheme 2.8). However, the !H NMR spectrum showed no 
proton signal for the imine. Similarly, the reaction with 
hexahydroazepine gave the same result.
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1. NBS.
— X -
2. NEt3
H
(25)
N
(4)
Scheme 2.8
In an adaptation of the work by Rapoport and co-workers9, 
pipecolinic acid (11) was heated briefly with phosphorus 
oxychloride. Extraction of the basified solution with cold ether 
gave a yellow solid with spectral properties identical to 
tripiperideine (79) (Scheme 2.9).
f  POCl3, 3 min, 110°C
JL  >-
N CD2H 
H
(11)
Scheme 2.9
Moriarty and co-workers reported the use of iodosobenzene 
(148) in the synthesis of 6-valerolactam (80) from pipecolinic acid 
and piperidine.55 Oxidative decarboxylation of the amino acid 
under neutral conditions, in dichloromethane or water, was 
thought to proceed via initial imine formation, as shown in 
Scheme 2.10.
N
Not isolated 
(4)
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N'
H
(11)
Ph 1
N
(4)
(PhIO)
H
(80)
Scheme 2 .1055
The oxidation of piperidine is thought to proceed via an 
initial nitrogen-iodine type intermediate (81) which dissociates to 
give 1-piperideine (Scheme 2.11). The imine is then believed to 
react with a second equivalent of iodosobenzene and water to give 
6-valerolactam (80). It was thought that if  the oxidation of 
pipecolic acid and piperidine could be undertaken in non-aqueous 
conditions with one equivalent of iodosobenzene it might be 
possible to isolate 1-piperideine from the reaction mixture.
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H
(25)
d 4 « r
H?0
OH
(81)
N
(4)
(PhIO)n
 >-
H?0
a i
— Ph
OH
Scheme 2 .1 155
 ' V  t i l
H
(80)
Iodosobenzene (148) was prepared by the treatment of 
iodosobenzene diacetate with aqueous sodium hydroxide.56 
Iodosobenzene and one equivalent of piperidine were mixed 
together in dry dichloromethane in the presence of crushed 
molecular sieves (Scheme 2.12). The mixture was filtered and 
zinc iodide added to the filtrate. No complex was formed. In the 
absence of zinc iodide the organic solution was evaporated to 
dryness. The lH NMR spectrum showed no imine proton signal. 
The reaction between pipecolic acid and iodosobenzene gave the 
same result (Scheme 2.13).
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N 
H
(25) 
Scheme 2.12
1.(PhIO)n, 1 equiv., 
CH2Q2, 15min, 
molecular sieves. 
  ►
2.Zinc iodide
COMPLEX
(66)
Scheme 2.13
GOOH
1.(PhIO)n, 1 equiv.,
CH2a 2, 24h,
molecular sieves.
 ^  COMPLEX
2.Zinc iodide (6 6 )
Since all attempts at complexing 1-piperideine with zinc 
iodide proved unsuccessful, the imine was used directly in the 
synthesis of pelletierine (82) and 3,,4,-dimethoxy-2,-(2- 
piperidyl)acetophenone (31).
2.6 The Use of l-Pioerideine with 8-Ketoacids
In a synthesis of pelletierine (82) adapted from that of 
Gupta and Spenser57, 1-piperideine was prepared from L-lysine 
monohydrochloride and N-bromosuccinimide. The aqueous 
solution of the imine was added to lithium acetoacetate (83) in 
phosphate buffer to give pelletierine in 68% yield (Scheme 2.14). 
The lH NMR spectrum of the product showed a singlet at 6 2.14 
which integrated to three protons, for the methyl group, and in 
the IR spectrum the carbonyl stretch appeared at 1720 cm*1.
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oLYSINE HC1 +
N
(4) pH 7, RT 
24h.
QOOH
(83)
Scheme 2.14
N'
H
(82)
O
3 \4 ,-Dimethoxy-2f-(2-piperidyl)acetophenone (31) was 
prepared in a similar manner from lysine and 3I,4'- 
dimethoxybenzoylacetic acid (72) in 70% yield (Scheme 2.15). The 
1R spectrum showed the carbonyl absorption at 1675 cm“l  and 
the high resolution mass spectrum gave a molecular ion at 
263.1515 in accordance with a theoretical value of 263.1521. 
These values, along with the other spectroscopic properties are in 
accordance with literature values. 15
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oLYSINE HC1
N
(4)
CH GOOH
+
(72)
pH 7, RT, 
24h.
OCH
OCH
(31)
Scheme 2.15
2.7 The Use of 1-Pinerideine in Diels-Alder Cvcloaddition  
Reactions
1-Piperideine is known to react with methyl 2,4- 
pentadienoate (78) to give methyl 1,2-didehydro-quinolizidine-l- 
carboxylate (84).58 It was of interest to us to see if this reaction 
could be adapted for a variety of dienes as a convenient route to a 
range of quinolizidine structures.
Methyl 2,4-pentadienoate (78) was prepared from acrolein 
(85) and malonic acid (8 6 ) in pyridine followed by treatment of 
the resultant acid (87) with an excess of diazomethane (Scheme 
2.16).59 Tripiperideine (79) and methyl 2,4-pentadienoate were
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heated together in a sealed tube with a catalytic amount of 
potassium hydrogen sulphate to give (8 8 ), which then underwent 
a double-bond isomerisation to give the a,p-unsaturated ester
(84) (Scheme 2.17). Stereoselective hydrogenation of (84), in the 
presence of platinum oxide catalyst gave the saturated ester (89). 
Reduction of the ester with lithium aluminium hydride afforded 
(+)-lupinine (21). The lH NMR spectrum of the product showed a 
doublet at 6 3.68 for the methylene of the alcohol group, and a 
broad singlet at 6 5.15 for the -OH signal. The high resolution 
mass spectrum gave a value for the molecular ion of 169.1463 in 
accordance with a theoretical value of 169.1466.
Pyridine
(85) (8 6 )
Scheme 2.1659
(87) (78)
For 1H NMR spectrum of lupinine (21) see Figure 2.4.
4 - ’ - Ji3?-
Figure 2.4
<d 2ch3
N 
(79)
+
3
(78)
KHSO.
Sealed Tube 
150°C
G32CH:
H2 /  PtO
MeOH
CD2CH.
(88)
CD2CH:
i
(89)
LiAlH4 , RT 
24h.
CH2CH 
H r
(84)
Scheme 2.17
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The reaction of 1-piperideine with a variety of dienes was 
then attempted. Table 2.2 shows a summary of the reaction 
conditions tried and the results obtained.
Source of Diene
1-Piperideine
Solvent Temp Time Result
L-Lysine HC1 2,3-Dimethyl- H20 RT 18h no reaction
1,3-butadiene DMF RT 18h no reaction
Tripiperideine neat 150°C 24h no reaction
Tripiperideine Methyl 2,4- neat 140°C 24h mixture of
hexadienoate products
Tripiperideine 2,4-penta- DMF 
dienoic acid
DMF
RT 24h mixture of
products 
70°C 24h mixture of 
products
Tripiperideine l-Acetoxy-1,3 neat 70°C 24h no reaction
-butadiene
Table 2.2
As shown in Table 2.2, no success was achieved despite the 
range of solvents, temperatures and sources of 1-piperideine 
tried.
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2.8 Synthesis o f  T e tracyc lic  O u in o liz id in e  A lka lo ids
Sparteine (90) is an alkaloid of the lupin family (Fabaceae) 
and is one of the more common tetracyclic quinolizidine alkaloids. 
The synthesis of sparteine was attempted through initial 
formation of 8 -ketosparteine by an application of the Mannich 
reaction.13 Piperidine hydrochloride, acetone and
paraformaldehyde react by a symmetrical bis-Mannich 
condensation to give l.S-bis^piperidyO-S-pentanone 
dihydrochloride (91). Mercuric acetate oxidation of (91) gave the 
di-iminium ion (92) which cyclised to 8 -ketosparteine (93) 
(Scheme 2.18). The final step of Wolff-Kishner reduction to (+)- 
sparteine was not undertaken due to the low yields of (93) 
obtained. 8 -Ketosparteine was characterised by the IR spectrum 
carbonyl stretching frequency at 1725 cm*1. The high resolution 
mass spectrum gave a value for the molecular ion of 248.1879 
compared to 248.1888.
It was of interest to synthesise the corresponding five and 
seven membered compounds as sparteine analogues. l,5-bis(N- 
Hexahydroazepinyl)-3-pentanone dihydrochloride (94) was 
prepared from hexahydroazepine hydrochloride, acetone and 
paraformaldehyde as above. The attempted oxidation of (94) 
produced a mixture of products. Column chromatography failed to 
isolate the desired product.
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+ h2c=o +
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HOAc ,
98°C 
'‘V  3 hr.
5% HOAc 95°C 
Hg(OAc)2 (91)
N' 2HC1
N
+
4*
N'
O
(92)
(93)
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Scheme 2 .1 813
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(94)
Pyrrolidine hydrochloride, paraformaldehyde and acetone 
were treated in a similar manner. The product formed was 
extremely hydroscopic and was found to be a mixture of 
compounds. The desired product could not be isolated.
The testing of l,5-bis(N-piperidyl)-3-pentanone (91), 1,5- 
bis(N-hexahydroazepinyl)-3-pentanone (94) and analogues as 
inhibitors of pea seedling diamine oxidase is discussed in Chapter 
4.
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CHAPTER 3
REVIEW OF DIAMINE OXIDASE
3.1 The Importance of Diamine Oxidase________
Diamine oxidases are important due to the role that they play in 
polyamine metabolism in most organisms. These enzymes regulate 
cellular levels of polyamines. It is known that polyamines are 
essential for the growth and replication of all living cells.60
Diamine oxidases catalyse the oxidative deamination of a range 
of primary diamines to the corresponding amino aldehydes (Scheme
Scheme 3 .161
In general, there is no reliable or convenient method available 
for the above reaction which does not involve enzymes. The best 
substrates for diamine oxidase have been shown to be putrescine (8 ) 
and cadaverine (9).
3.1).61
H2N(CH2)3CH2NH2 + H 2O  +  O 2
Diamine oxidase
H2N(CH2)3CHO + H2Q2 + NH3
H2N(CH2)4NH2
(8)
H2N(CH2)5NH2
(9)
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Diamine oxidases are found in many biological tissues. Pig 
kidney diamine oxidase is commercially available, but a more active 
form of diamine oxidase can be isolated from 10  day old pea 
seedlings.61 Diamine oxidases have been found to contain copper, 
which is easily removed from the enzyme by dialysis against chelating 
agents resulting in deactivation of the enzyme. The enzyme activity 
can be restored on addition of small quantities of Cu2+salts.62
3.2 Polvamine Metabolism and Cell Growth
Polyamines such as putrescine (8 ), spermidine (95) and 
spermine (96) are present in all animals and higher plants and they 
have many important physiological roles.
Rapidly proliferating cells and tissues usually have greater 
concentrations of putrescine and spermidine than non-growing tissues. 
It has been suggested that this link between polyamines and growth is 
due to electrostatic interactions which serve to stabilise DNA, RNA and 
proteins. At physiological pH at least one amino group is protonated, 
which allows these groups to bind strongly to the phosphate groups of 
nucleic acids. Polyamines also affect the rate of each step in the 
transcription-translation sequence, whereby genetic information is 
coded for the manufacture of proteins.60
Polyamines are metabolised via the interconversion pathway 
and the so-called terminal polyamine catabolism pathway. The 
interconversion pathway regulates polyamine levels in the cell using a 
cyclic process to control polyamine turnover. Decarboxylation of
H2N(CH2)3NH(CH2)4NH2
(95)
H 2N(CH2)3NH(CH2)4NH(CH2)3NH2
(96)
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ornithine produces putrescine which in turn is the precursor of 
spermidine and spermine. Spermine is formed from spermidine, 
which itself is produced from putrescine using spermine synthase. In 
the catabolic branch of the interconversion cycle spermine is degraded 
to spermidine and spermidine to putrescine. This sequence starts 
with W-acetylation followed by oxidative splitting of the acetylated 
polyamines. Terminal polyamine catabolism is catalysed by amine 
oxidases which are Cu^+ dependent, of which only diamine oxidase has 
been well defined. Each intermediate of the interconversion cycle can 
serve as a substrate for a Cu2+ containing amine oxidase. The 
intermediates can then be transformed into the corresponding amino 
aldehydes following oxidative deamination of a primary amino group 
followed by further oxidation to an amino acid or a y-lactam. Since 
these products cannot be directly reconverted into polyamines these 
reactions are termed terminal catabolism. All products of terminal 
catabolism can be found in the urine.
Examining the consequences when the internal concentration of 
polyamines is depleted gives an insight into the workings of a 
biological system.
In the early 1970's a compound called 
a-difluoromethylomithine (DFMO) was synthesised by Merrell Dow 
Pharmaceuticals. Since DFMO is a close analogue of ornithine it reacts 
in the same manner with ornithine decarboxylase. Subsequently, 
DFMO was shown to possess anti-tumour activity and significant anti- 
fungal activity.60
In order to control the growth of rapidly proliferating cells such 
as tumours which have a higher demand for polyamines it is 
necessary to inhibit polyamine biosynthesis. It is possible that 
inhibitors of diamine oxidase may have interesting anti-cancer and 
anti-fungal properties.
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3.3 P u rifica tion  o f Diamine Oxidase
Diamine oxidases [DAO, EC 1.4.3.6; diamine: 0 2 -oxidoreductase 
(deaminating; copper containing)] occur widely throughout living 
organisms. Pea seedlings and pig kidneys are the main sources of 
these enzymes. Diamine oxidase can be extracted and purified from 
pea seedlings after a period of 8-16 days germination.63 Diamine 
oxidase has been purified separately from cotyledons and embryos of 
pea seedlings germinated for 6  days. These enzymes have been 
shown to differ in Km , with respect to putrescine and cadaverine, 
thermal stability and most significantly in electrophoretic mobility.64 
The enzyme has also been purified to homogeneity from pea 
epicotyls by the use of polyacrylamide gel electrophoresis. The 
purified enzyme (yield 35%) showed absorption maxima at 280 and 
500 nm and ornithine was not amongst the amino acids present. The 
molecular weight estimated by gel filtration was ca. 180,000 and the 
enzyme contained one mole of carbonyl group per mole. Sodium 
dodecylsulphate (SDS) gel electrophoresis gave a single band at a 
molecular weight of 85,000 suggesting that the enzyme is made up of 
two identical subunits.65
Purified pea seedling DAO contains 0.08-0.09% copper. Hill and 
Mann reported that copper is present in the Cu^+ form and does not 
change oxidation state during the enzymatic reaction. Copper is firmly 
bound to the protein but could be removed when dialysed with 
sodium diethyldithiocarbamate rendering the enzyme inactive. The 
activity could be restored by addition of C u ^ +  ions.62
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3.4 Cofactors for Diamine Oxidase
It is well known that diamine oxidases are sensitive to chelating 
agents of copper and carbonyl compounds such as hydrazine, 
phenylhydrazine and semicarbazide.66 This suggested that the active 
site of the enzyme contains a carbonyl group. Some researchers have 
proposed a role for pyroxidal phosphate as the cofactor in copper 
amine oxidases. Alternative theories have included the postulated 
role of a ring modified flavin67 or a sulphenic acid derivative.68 The 
perspective on cofactor structure changed in 1984 with reports from 
two independent groups that bovine plasma amine oxidase may 
contain pyrroloquinoline quinone (PQ.Q) (97) as the cofactor.
HOOC HN-
HOOC
O
(97)
3.5 Evidence for Pvrroloauinoline Quinone as the Cofactor in 
Copper Amine Oxidases
Duine and co-workers prepared a dinitrophenylhydrazone 
derivative of the bovine plasma amine oxidase before hydrolysing the 
protein.® The adduct was compared with an authentic derivative of 
PQQ using HPLC retention times for structural identification. The 
second approach by Ameyama et ai. used native enzyme which, when 
digested, yielded a chromophoric material with a fluorescence 
spectrum similar to PQH70
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The earliest indication of PQQ. as an enzymatic cofactor was by 
Hauge in 1964 from studies of a bacterial glucose dehydrogenase 
which indicated the presence of a dissociable cofactor which was 
neither a flavin nor a nicotinamide.71 He suggested that the structure 
was a substituted 1,4-naphthoquinone. At the same time Anthony 
and Zatman postulated a pteridine structure as the cofactor following 
studies on methanol dehydrogenase from Hyphomicrobium  X.72 
However, Duine and co-workers, using EPR found a hyperfine 
structure which was not compatible with a pterine cofactor.73 This 
structure was thought to contain quinone and two nitrogens which, 
following further investigation using X-ray crystallography was found 
to be the acetone adduct of PQQ, (98).
Glatz et al. investigated the effect of known ligands which form 
complexes with PQQ.74 The addition of borate ions to a solution of 
native enzyme resulted in fluorescence and absorbance properties 
similar to those of the mixture of PQQ. and borate ions.
The precise biological function and evolutionary significance of 
PQQ. in micro-organisms are as yet unclear, since the reactions 
catalysed by enzymes containing PQQ, can also be catalysed by 
enzymes using flavins and nicotinamides.
(98)
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3.6 The Mechanism o f O xidation Invo lv in g  POO
Various mechanisms have been proposed for the reaction of the 
PQQ,-containing enzyme. The mechanism of substrate oxidation by 
PQQ, in methanol dehydrogenase was thought to be activated by 
ammonia or primary amines. Forrest et al suggested that the C-4 
position of the cofactor interacts with amines to generate the 
compound (99) shown below.75
HOOC
•NHRHOOC
O
(99)
Attack by one amino group of the substrate leads to a 
carbinolamine derivative which followed by oxidation produces the 
reduced aminoquinol of PQQ, (Scheme 3.2).
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Scheme 3.2
However, literature concerning PQQ, indicates that the C-5 
position has an unusually high reactivity towards nucleophilic attack. 
Subsequently, a simple mechanism can be argued involving initial 
formation of a hemiacetal followed by oxidation of the substrate to 
yield the reduced quinol of the cofactor (Scheme 3.3).
O
O HO
OH
;a h
Scheme 3.3
The reduced quinol form of PQQ is a major product in amine 
oxidation, which allows an analogous mechanism to be suggested 
(Scheme 3.4).
O
O
RCH2NH2 
 >-
Scheme 3.4
OH
OH
+ j? + n h 3
rA„
Since amines, unlike alcohols, can generate stable Schiff base 
intermediates with PQQ, a minor pathway has been reported by Bruice 
and co-workers76 and Itoh etal. 77 (Scheme 3.5).
HN
CH
HN
\
H *'
\
H*' J H
- fH 2 0
Scheme 3.5
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Hartmann and Klinman have reported a large amount of 
evidence indicating that the enzymatic reaction proceeds by the latter 
aminotransferase mechanism.78 This evidence includes reductive 
covalent binding of the substrate to the enzyme with the reagent 
NaCNBH3 which specifically reduces imines. They have also examined 
the stoichiometric transfer of nitrogen from substrate to cofactor 
following reduction of the cofactor. Only under conditions of imine 
formation is a covalent transfer of nitrogen to the reduced cofactor 
expected. However, under anaerobic conditions to prevent cofactor 
reoxidation, Knowles and co-workers observed a burst of ammonia 
production with porcine plasma amine oxidase.79 This result appeared 
to rule out an aminotransferase mechanism. However, a subsequent 
study by Linstrom and Pettersson which compared native and 
inhibited enzyme showed no difference in ammonia release.80
3.7 Evidence Against Pvrroloauinoline Quinone (POO) as the 
Cofactor
Despite the vast amount of research undertaken on PQQ, 
disagreement still exists on its distribution. This is due to the fact that 
there is no agreement with respect to the reliability of some detection 
methods for PQQ, Recent developments have shown that the finding 
PQQ, covalently bound to the enzyme is unlikely in a number of cases. 
X-Ray diffraction studies on methylamine dehydrogenase have shown 
that the electron density map of the cofactor in the active site does not 
correspond to PQQ,81 Plasma amine oxidase has been reported to form 
a hydrazone derivative under mild conditions which was hydrolysed 
with thermolysin to produce the hydrazone of 6 -hydroxydopaquinone 
or topaquinone (topa) (100).82 This suggests that the original
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hydrazine method in fact converted the hydroxydopaquinone into PQQ. 
by an as yet unknown sequence of reactions.
H2N c GOOH
CH
HO
OH
OH
(100)
Both topa and dopaquinone are very reactive compounds leading 
to a lack of knowledge about their properties. The absorption maxima 
of topaquinone however have been reported.83 There is disagreement 
about the occurrence of topa in mammalian systems.^
Falk and co-workers have reported the effects of plasma amine 
oxidase inhibited with fluorinated phenylhydrazines and 
acridinylhydrazines.85 From l9F-NMR and fluorescence spectroscopy 
respectively they have shown that no direct interaction could take 
place between the Cu2+ ion and topaquinone or the substrate.
However ESR spectroscopy revealed that electron transfer takes 
place from the reduced topaquinone to Cu2+ since an organic free 
radical was observed, which is likely to derive from the cofactor.86 It 
is thought that this Cu-semiquinone state may be involved in the 
reoxidation of the substrate-reduced enzyme by O2. This observation 
only occurs in plant amine oxidases but can be induced in others by 
addition of substrate and cyanide.87
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In view of the similarity in the type of inhibitors and 
spectroscopic properties of copper-containing amine oxidases, it is 
thought likely that topaquinone is the cofactor for all of them. The 
most conclusive evidence for topaquinone as the cofactor in pea 
seedling diamine oxidase was reported by Klinman and co-workers.88 
They isolated an active site, cofactor-containing peptide of pea 
seedling diamine oxidase by derivatisation with p- 
nitrophenylhydrazone. This peptide was characterised by resonance 
Raman spectroscopy. This spectrum showed identical peak positions 
and intensities relative to a model p-nitrophenylhydrazone derivative 
of topaquinone hydantoin establishing topaquinone as the cofactor. 
This approach was also used for enzymes from porcine plasma and 
porcine kidney. In each instance topaquinone was established as the 
cofactor.
This year the amine oxidase from pea seedlings has been 
crystallised and has undergone preliminary crystallographic 
characterisation.8^  These results show that the unit cell is 
orthorhombic and that the mass of the asymmetric unit is 131 (±13) 
kDa which is in agreement with evidence that the molecule consists of 
two identical subunits of approximately 66  kDa. The detailed X-ray 
structure should reveal the nature of the cofactor.
3.8 Substrate Specificity In Pea Seedling and Pig Kidnev 
Diamine Oxidase
In 1952 Kenten and Mann reported that both mono- and di­
amines were oxidised by extracts of pea seedlings accompanied by a 
release of hydrogen peroxide.63 Of the mono amines tested, tyramine, 
tryptamine and mono- and di-p-phenylethylamine were the best 
substrates. Kenten and Mann concluded that, from their evidence, one
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enzyme catalysed the oxidation of all the amines tested. Of the 
diamines tested 1,6 -diaminohexane was a poorer substrate than 
putrescine and cadaverine and no activity at all was observed with 
1,3-diaminopropane or 1,2-diaminoethane. The diamines were more 
readily oxidised than the mono-amines, indicating the importance of 
the second amino group. With the animal enzyme the rate of 
oxidation increases with the length of the carbon chain up to 
cadaverine, including 1,3-diaminopropane. !i4 This would seem to 
suggest that the active sites of the plant and animal enzymes are 
different. However, Robins and co-workers reported that both 1,3- 
diaminopropane and 1 ,2 -diaminoethane are in fact substrates of pea 
seedling diamine oxidase, though poor.9° They also reported the 
significant chain length dependance of both the substrate binding 
affinity and the catalytic rate of oxidation. As the carbon chain length 
is increased to C5-C7 the binding affinity of the substrate rises, but 
diminishes for longer diamines. The catalytic rate has a maximum 
activity for C5 and again decreases for longer diamines.
Macholan and co-workers investigated the oxidation of 2- 
hydroxyputrescine ( 1 0 1 ) and 2 -hydroxy cadaverine ( 102 ) with 
partially purified pea seedling and pig kidney diamine oxidase.91
(101) OH (102)
(103)
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They found that neither was as good a substrate as putrescine or 
cadaverine but that 2 -hydroxyputrescine was a better substrate for 
pig kidney diamine oxidase that 2 -hydroxycadaverine and vice versa 
for the plant amine oxidase.
In a later paper Macholan again tested compounds (101) and 
(102) along with 3-hydroxycadaverine (103).92 Putrescine and 
cadaverine were oxidised with comparable rates by pea seedling and 
pig kidney diamine oxidase at pH 7.62>93 in the series of 
hydroxyamines tested the optimal pH values for pig kidney diamine 
oxidase were found in general to be shifted to the alkaline region in 
contrast to the plant enzyme. Macholan also found that 3- 
hydroxycadaverine (103) had the lowest binding affinity to pea 
seedling diamine oxidase. However, it had the highest affinity to the 
animal enzyme. These differences in behaviour suggest that certain 
distinctions in the structure of the active sites of these enzymes do 
exist.
3.9 Inhibitors o f Diamine Oxidase
Virtually all modern drug treatments are based on the concept 
of inhibition of enzymatic activity. Drugs are designed to inhibit a 
specific enzyme in a particular metabolic pathway. Product inhibition 
in a metabolic pathway provides a means of controlling or modulating 
the flow of substrate through the pathway.
Enzyme inhibition can be divided into two main types; 
reversible and irreversible.
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In reversible inhibition the enzyme-inhibitor complex 
dissociates very rapidly, whereas an irreversible inhibitor binds very 
tightly to the enzyme and the complex formed dissociates very slowly.
Within reversible inhibition there are two main classes of 
inhibitor; competitive and noncompetitive. In competitive inhibition 
the enzyme can bind to the substrate and the inhibitor but not at the 
same time. The inhibitor binds at the same active site of the enzyme, 
and competes with the substrate for the enzyme, and in so doing slows 
the rate of reaction. The enzyme-bound inhibitor then either lacks the 
appropriate reactive group and cannot be processed by the enzyme, or 
it is held in an unfavourable position with respect to the catalytic site 
resulting in a dead-end complex. The inhibitor can then be displaced 
from the enzyme and replaced by substrate. Many competitive 
inhibitors are analogues of substrates.
A noncompetitive inhibitor binds at a different active site from 
the substrate. The enzyme can therefore bind to the inhibitor and the 
substrate at the same time. The inhibitor acts as if  it were removing 
active enzyme from the solution. Thus the inhibitor decreases the 
turnover number of the enzyme, hence decreasing the Vmax, rather 
than decreasing the number of substrate molecules bound to the 
enzyme (Figure 3.1).
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Figure 3.1
Kenten and Mann investigated the effect of a number of 
inhibitors on the oxidation of p-phenylethylamine and putrescine by 
pea seedling diamine oxidase.63 The oxidation of both the mono- and 
di-amine were inhibited strongly by a 0 .01M solution of cyanide, 
semicarbazide and iso-amylamine. However the oxidation of the 
monoamine but not that of the diamine was inhibited by p- 
benzoquinone indicating the possibility that specific enzymes are 
present for mono- and di-amine oxidation.
Other types of inhibitors are copper (II) chelating agents such as 
8 -hydroxyquinoline, 2 ,2 '-bipyridyl, 1 ,10 -phenanthroline and sodium 
diethyldithiocarbamate.61 Diamine oxidases are also sensitive to many 
carbonyl reagents and especially to hydrazine.66
Substrate analogues are often found to be very good inhibitors. 
The competitive inhibition of pea seedling and pig kidney diamine 
oxidase with l,5-diaminopentan-3-one has been reported.9+ The 
ketodiamine proved to be a more effective inhibitor of the plant 
enzyme than the mammalian enzyme. The duration of inhibition 
depended on the amount of enzyme present, indicating that an 
enzymic degradation of the inhibitor was occurring.
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The structural relationships between the diamine oxidase 
substrates histamine and putrescine and some inhibitors with respect 
to the plant and animal enzymes were investigated by Buganski and 
co-workers.^5 They were interested in whether the imidazole 
derivatives would be more inclined to inhibit the pig kidney enzyme 
rather than the plant enzyme. Compounds (104) and (105) were 
found to be potent inhibitors of diamine oxidase with no particular 
bias to either enzyme.
Compound (106) showed some selectivity towards inhibiting the 
pea seedling diamine oxidase in contrast to the two guanidine 
derivatives (107) and (108) which contain the imidazole ring structure 
but are not amines. These compounds only inhibited the animal 
enzyme.
CH2CH2NHNH2CH2ONH2
(104) (105)
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CH2CH2CH2NHCH2CH2NH2
ch2ch2ch2nhc n h2
II
(106) NH
(107)
H3C ch2sch2ch2nhcnhch3
II
NH
hn^ n
(108)
Therefore the possession of an imidazole ring by a substrate 
analogue does not appear to cause a differential inhibition of pig 
kidney diamine oxidase with respect to the substrates histamine or 
putrescine.
Pec and co-workers investigated a range of lysine derivatives 
including L-lysine hydrazide as inhibitors of pea seedling diamine 
oxidase.96 All the compounds tested were competitive inhibitors. In 
the case of L-lysine hydrazide the inhibition was found to be time 
dependent and partly reversible. The enzyme can be protected by an 
excess of substrate by addition of a hydrazide sensitive compound 
such as sodium pyruvate.
Pec and Frebort reported the inhibition of pea seedling diamine 
oxidase by a range of piperidine alkaloids and aromatic aminoketones 
and compared the binding sites for inhibition.97 The alkaloids tested 
were L-lobeine, (-)-norsedamine and cinchonine and the aromatic 
ketones were 1-amino-3-phenylpropan-3-one and 1-amino-3-
phenylpropan-2-one. In all cases they obtained evidence to indicate
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that all the compounds are bound into the same subsite of the enzyme. 
They concluded that for compounds so structurally different to be 
bound at the same subsite, the active site of the enzyme is on the 
surface or in an exposed opened pocket.
Recently a set of aminoalkylaziridine analogues of putrescine, 
cadaverine and 1,3-diaminopropane were found to inhibit pig kidney 
diamine oxidase irreversibly.98
(109) ( 110)
(111)
N-(4-Aminobutyl)aziridine (109) and N-( 5-
aminopentyl)aziridine (110) were found to be, respectively, 35 and 15 
times more effective as inhibitors than the 1,3-diaminopropane 
derivative (111). The differences in reactivity of the 
aziridinylalkylamines may be related to an association of the 
inhibitors with specific sites on the enzyme. These results suggest 
that the aziridinylalkylamines tested are site-directed agents which 
form irreversible complexes at the active site of pig kidney diamine 
oxidase. N-(4-Aminobutyl)aziridine (109) is a potent reversible 
inhibitor of polyamine uptake^ and has been evaluated as a potential 
chemotherapeutic agent for prostatic cancer.100
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3.10 Uses o f D iam ine Oxidase
As disscussed in Chapter 1 Herbert and co-workers have 
described convenient synthetic routes to tylophorine (3) and 
cryptopleurine (33) using the enzymic action of diamine oxidase to 
generate 1-pyrroline and l-piperideine.Hl5
For example, 3,4-dimethoxybenzoylacetic acid (72) was 
condensed with 1-piperideine, generated from the oxidation of 
cadaverine by pea seedling diamine oxidase, to give 3,,4'-dimethoxy- 
2-(2-piperidyl)acetophenone (31) which is an intermediate in the 
synthesis of cryptopleurine (33).
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CHAPTER 4
THE INHIBITION OF DIAMINE OXIDASE
4.1 Isolation and Purification of Diamine Oxidase (DAO).______
There are two main sources from which the enzyme, diamine 
oxidase, can easily be isolated. These are pig kidneys and peas. Pea 
seedling diamine oxidase was found to be preferable for our work as 
the enzyme isolated from pig kidneys is too impure as supplied 
commercially and it would be difficult and expensive to produce 
enzyme with sufficient activity to carry out kinetic determinations. 
Also, the pea seedling enzyme is very stable during long-term storage.
Pea seedling diamine oxidase was extracted and partially 
purified using the method of Hill.61 The extraction and purification 
procedure was carried out by Miss I. Freer in the University of 
Glasgow. Pea seedlings from the 'Fillbasket' variety were grown for 
ca. 10 days. Precipitation with a mixture of chloroform and ethanol 
(2:1) removed unwanted material from the crude extract. Subsequent 
saturation with ammonium sulphate precipitated the enzyme after 
one hour. Unlike Hill’s preparation, complete separation of the 
enzyme was not obtained by us after one hour of standing, and it was 
decided to improve separation by allowing the mixture to stand 
overnight. Further precipitation by ammonium sulphate, then 
dialysis, led to the isolation of the partially purified enzyme. There 
was no need to undertake the chromatographic purification steps 
described by Hill, as the enzyme obtained was pure enough for our 
purposes. The enzyme was then taken up in phosphate buffer (pH 7) 
and stored in 0.5 ml aliquots in the freezer at ca. -20 °C. The enzyme 
was found to be stable, under these conditions, for several months.
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4.2 D eterm ination o f the Prote in C oncentra tion
The method of Sedmark and Grossberg101 was used to determine 
the protein concentration of the enzyme. This was carried out by Dr. 
A. M. Tierney in the University of Glasgow. This method works on the 
principle that Coomassie brilliant blue G in dilute acid changes from a 
brownish/orange to an intense blue colour with the addition of 
protein. This method was carried out using bovine serum albumin 
(BSA) as standard (1 mg of BSA is equivalent to 1 mg of protein). For 
various concentrations of BSA the absorbances of the mixture at 620 
nm (A62o)(blue) and 465 nm (A^65)(brownish/orange) were recorded 
immediately after the protein was added. A standard graph was 
obtained by plotting A620/  A465 against the protein concentration. The 
A620 and A465 absorbances were then measured for a range of enzyme 
samples of varying dilutions. The A620/A 465 absorbance ratios then 
allowed the determination of the protein concentrations in the enzyme 
samples, by using the standard graph.
This assay has been shown to be highly reproducible for the 
determination of protein concentration.
4.3 Enzvme Kinetics
4.3a Michaelis-Menten Kinetics
Generally the initial rate (V) of an enzyme-catalysed reaction 
increases with increasing substrate concentration ([S]) as shown in 
Figure 4.1. The rate of product formation is directly in proportion to 
the substrate concentration. As the substrate concentration increases
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further, the enzyme becomes saturated with substrate, and a maximal 
rate is reached.
Reaction
rate
(V)
max
1/2 V,max
Substrate concentration ([S])
Figure 4.1 Reaction Rate (V) against Substrate Concentration ([S])
The Michaelis-Menten model is a simple one which accounts for 
the kinetic properties of most enzymic reactions. i°2 Here the 
mechanism of enzyme action must involve the formation of a specific 
complex between the enzyme and the substrate as an intermediate 
(Scheme 4.1).
k i  k Cat
E + S ES ------E + P
k2
where E = Enzyme, S = Substrate, ES = Enzyme-Substrate Complex, P = 
Product.
Scheme 4.1
The rate constant for formation of this ES complex is defined as 
ki, and the rate constant for dissociation is defined as k2. The rate
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constant for the conversion of the complex into the products is defined 
as kcat*
Firstly, a rate equation is required which relates the rate of 
catalysis to the substrate and enzyme concentrations and the rates of 
the individual steps. The rate of catalysis (V) can be expressed as 
being equal to the product of kcat and the concentration of the ES 
complex (Equation 4.1).
V = kcatPES]
Equation 4.1
The ES complex is assumed to be under steady state conditions, 
that is the rates of formation and breakdown of ES are equal.
Rate of formation of ES = ki[E][S]
Equation 4.2
Rate of breakdown of ES » ( k 2 + k c a t ) [ E S ]
Equation 4.3
therefore,
k i [ E ] [ S ]  =  ( k 2 + k c a t ) [ E S ]
Equation 4.4
i.e. [E S ] =  [ E | [ S ]  /  { ( k 2 + k c a t ) / k i }
Equation 4.5
By defining the Michaelis-Menten constant, Km  as,
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Km  = (kz+kca t) /  k i
Equation 4.6
Equation 4.5 can be simplified to,
[ES] = [E][S] /  KM 
Equation 4.7
Provided that the enzyme concentration is much smaller than 
the substrate concentration, the concentration of free substrate [S] is 
effectively equal to the total substrate concentration. The 
concentration of free enzyme [E] must be expressed in terms of the 
total enzyme concentration [ E t ]  minus the enzyme concentration in the 
[ES] complex:
i.e. [E] = [Ei] - [ES]
Equation 4.8
Substituting this expression for [E] into equation 4.7 gives,
[ES] = ([Et]-[ES])[S] /  KM 
Equation 4.9
i.e. [ES] = [ET][S] /  ([S]+KM)
Equation 4.10
Substituting this expression for [ES] into equation 4.1 gives,
V = kcattExHS] /  «S]+KM)
Equation 4.11
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The maximal rate Vmax, is observed when the enzyme active 
sites are saturated with substrate, that is when [S] is far greater than 
Km, so [S]/[S]+Km approaches 1. Therefore,
V  max = ^cattth!
Equation 4.12
Substituting this expression for kcatpT] in equation 4.11 gives 
the Michaelis-Menten equation,
V -  Vmax[S] /  ([S]+KM)
Equation 4.13
At low substrate concentrations, when [S] is much smaller than
Km ,
V = Vmax[S] /  KM 
Equation 4.14
The rate is therefore directly proportional to the substrate 
concentration. At high substrate concentrations, when [S] is much 
greater than Km ,
V = Vmax 
Equation 4.15
The rate is therefore maximal and independent of the substrate 
concentration.
When the substrate concentration is equal to the Km ,
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v = V m a x /  2
Equation 4.16
The Km  is therefore equal to the substrate concentration at 
which the reaction rate is half its maximal value.
4.3b The Determination of and Vyn^
Both the Michaelis constant Km , and the maximal rate Vmax, can 
be determined by the measurement of the rate of catalysis at various 
substrate concentrations, for an enzyme catalysed reaction which 
obeys Michaelis-Menten kinetics.
However, in practice the plot of reaction rate (V) against 
substrate concentration [S] is not satisfactory for the determination of 
Km  and Vmax> since Vmax is approached asymptotically.
The reciprocal of equation 4.13 separates the variables into an 
equation consistent with the familiar y = mx+c format for a straight 
line,
i.e. 1/V -  KM/V max(l/[S]) + 1/Vmax
Equation 4.17
A plot of the reciprocal of the reaction rate ( 1 / V )  against the 
reciprocal of the substrate concentration (1 / [S ] ) ,  gives a straight line 
whose gradient of the slope is KM/Vmax and whose y intercept is 
1 /V m a x  (Figure 4.2). This is known as the Lineweaver-Burk plot.103
The accuracy of this double reciprocal plot is however widely 
criticised due to the undue weight given to low substrate 
concentrations, and these values are not as accurate.
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The Michaelis-Menten equation can be rearranged to give V as a 
function of V/[S],
V  = -K M (V /[S ] )  +  V max 
Equation 4.18
1 / V
max
Intercepts 1/K j
Intercept=l/V,max
1/[S]
Figure 4.2 The Lineweaver-Burk Plot
A plot of V  against V/[S], known as the Eadie-Hofstee plot, is also 
a straight line with the gradient equal to -Km and the y intercept 
equal to V max (Figure 4.3).10*
The Eadie-Hofstee plot is generally considered to be more 
accurate than the Lineweaver-Burk plot.
In te rc e p t^max
V
slope=-Kj
Intercept-Vmax/K]
V /[S ]
Figure 4.3 The Eadie-Hofstee Plot
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4.3c The Im portance o f Kj^ and V ^nv
The Km is related to the rate constants of the formation and 
dissociation of the ES complex. If k2 is much greater than kcat then,
Km = k2 /  k i 
Equation 4.19
and the dissociation of the ES complex is given by,
Kes = [E ][S ]/[E S ]-k2 / k i  
Equation 4.20
That is the Km is equal to the dissociation constant of the ES 
complex if k2»kcat-
Therefore under this condition the Km is a measure of the 
strength of the ES complex. A high Km  indicates weak binding of the 
substrate to the enzyme and a low Km indicates strong binding of the 
substrate to the enzyme.
The V max is the maximal rate and is related to the rate of 
formation of the products, kcat- The V max is a measure of the 
turnover number of the enzyme.
4.4 Enzvme Kinetics for Inhibitors o f Diamine Oxidase
It is possible to distinguish between competitive and 
noncompetitive inhibitors by studying the rates of catalysis in the 
presence and absence of an inhibitor at different substrate 
concentrations.
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In the presence of a competitive inhibitor the Lineweaver-Burk 
plot has the same appearance as that in the absence of inhibitor. A 
competitive inhibitor does not affect the turnover number of the 
enzyme so the V max does not change. The plot, therefore, has the 
same y intercept (1 /V max). Since the substrate and the inhibitor are 
competing for the same active site of the enzyme, the Km shows an 
apparent increase in the presence of inhibitor. Therefore both the x 
intercept (-1 /K m ) and the slope of the line (KM/Vmax) change (Figure 
4.5).
+competitive inhibitor
no inhibitor present1 / V
1/[S ]
Figure 4.5 Double Reciprocal Plot for Competitive Inhibition.
The difference in the slopes of the lines indicates the difference 
in binding. The Lineweaver-Burk equation,
1 /V  = 1 /V m a x  +  K M / V m a x ( l / [ S ] )
Equation 4.21
becomes,
1 /V  -  1 /V max +  K M / V m a x ( l + [ I ] / K i ) ( l / [ S ] )
Equation 4.22
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Where [I] is the inhibitor concentration and Ki is the dissociation 
constant of the enzyme-inhibitor complex. Therefore,
(slope)I/(slope) = 1 + [I]/Ki 
Equation 4.23
Where (slope)* is the slope of the line with competitive inhibitor 
present, and (slope) is the slope of the line without inhibitor.
In noncompetitive inhibition the Vmax is decreased and the Km 
remains unchanged. This effect is seen graphically in the double 
reciprocal plot (Figure 4.6).
+ Noncompetitive inhibitor
1 /V
No inhibitor present
1/[S]
Figure 4.6 Double Reciprocal Plot for Noncompetitive Inhibition.
Since Km  remains unchanged, the maximum velocity in the 
presence of a noncompetitive inhibitor is given by,
Vmax* = Vmax/(1+[I]/Ki) 
Equation 4.24
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4.5 The S pectrooho tom etric  Assay
The kinetic data for diamine oxidase catalysed oxidation of a 
substrate in the presence of an inhibitor were determined using the 
procedure of Stoner.105 This involved a peroxidase-coupled assay 
(horseradish peroxidase, EC 1.11.1.7, from Sigma) to monitor 
continuously the production of hydrogen peroxide during diamine 
oxidation at 25 °C, in 70 mM phosphate buffer (pH 6.3), in the 
presence of 3-methyl-2-benzothiazolinone hydrazone (MBTH) (112) 
and 3-(dimethylamino)benzoic acid (DMAB) (113). Oxidative coupling 
generated stoichiometric quantities of an indamine dye (114) with a 
characteristic absorbance at 595 nm (Scheme 4.2). The rates of 
reaction could be determined directly in the spectrophotometer. 
Initial rates were determined over a range of substrate concentrations 
from the linear absorbance changes measured during the first thirty 
seconds of reaction. For inhibition studies, four separate experiments 
were carried out. A constant amount of inhibitor was added to each 
experiment. Typically,
(1) Substrate only
(2) Substrate + [I]
(3) Substrate + 2[I]
(4) Substrate + 4 [I]
where [I] is the inhibitor concentration.
Since experimental values for the oxidation can vary slightly 
from day to day it was necessary to obtain rate data for the substrate 
alone for every inhibition study. The oxidation was initiated by the 
addition of the enzyme to the thermally equilibrated reaction mixture. 
The same concentration of inhibitor was added in each experiment
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followed immediately by the substrate. The reaction mixture was 
shaken, before both the inhibitor and the substrate were added (see 
Experimental section for more details of assay system).
Michaelis-Menten behaviour was observed in most cases. Rate 
data were analysed for Km and Vmax by least squares fitting of 
Lineweaver-Burk (1 /V  vs 1 / [S]) and Eadie-Hofstee (V vs V/[S]) plots.
N(CH3)2
(112)
(113)
Peroxidase
N(CH3)2
(114)
Scheme 4.2 The Spectrophotometric Assay105
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4.6  N-Alkvlated Amines as Inhibitors of Pea Seedling
Diamine Oxidase 
4.6a Introduction
A range of diamines ( 1 1 5 ) - ( 1 18) ,  ( 5 4 )  and ( 1 2 1 ) - ( 1 2 3 )  were 
tested as substrates of pea-seedling diamine oxidase by Alastair 
Denholm106 using the peroxidase coupled assay system. Compounds
( 1 1 5 ) - ( 1 2 0 )  and ( 1 2 1  ) - ( 1 2 3 )  are analogues of a known intermediate 
( 5 4 )  in pyrrolizidine alkaloid biosynthesis.37
The five membered saturated compounds ( 1 1 5 )  and ( 1 1 7 )  were 
found by Denholm to have a similar binding affinity, as shown by the 
Km  values, to putrescine and the Km  values of the six membered 
compounds ( 1 1 6 )  and ( 1 1 8 )  were similar to that of cadaverine. 
However, there was a large decrease in the V max for all four 
compounds, indicating a lower activity compared to the natural 
substrates putrescine and cadaverine (see Table 4 .1 ) .  The unsaturated 
amines (5 4 ) ,  ( 1 2 1 )  and ( 1 2 2 ) - ( 1 2 3 )  were shown to have a far higher 
binding affinity for pea seedling DAO than putrescine and cadaverine. 
These compounds also showed a lower rate of oxidation, indicated by a 
decrease in the V max (see Table 4.2 ) .  This stronger binding effect may 
be due to a number of changes produced by the presence of the C=N+ 
double bond. Changes in the pKa of the remaining amino group and/or 
polarity of the molecule may be important, as well as the change in 
conformation of the ring system and the presence of the n system. 
Due to the good binding affinities and low rates of oxidation shown by 
these compounds it was decided to test them as inhibitors of pea 
seedling diamine oxidase with cadaverine as the substrate.
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NH
2cr (116)
NH
2Cf2cr
(118)
NH
+
NH3
2cr
(119)
( 120)
2cr
(122)
Substrate
(115)
(117)
(116)
(118)
Table 4 .1 106
(123)
2C1
NH
2cr2cr
(121)(54)
2cr
KM(mM)
0.94(30.04)
1.19(30.11)
0.20(30.02)
0.37(30.03)
Vmax(»Arnol m g - lh " l )
31.9(30.85)
5.43(30.05)
17.2(30.42)
3.57(30.25)
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Substrate Km (h iM) V max(nmol mg’ 1 h- 1)
(54)
( 122)
(121)
(123)
0.052(30.005) . 15.7(30.78)
0.056(30.003) 7.69(30.46)
0.035(30.003) 25.3(30.92)
0.037(30.004) 7.96(30.53)
Table 4 .2 1(*>
4.6b Synthesis of N-A lkvlated Amines
For our work, compounds (115)-( 118), (54) and (121)-(123) 
were prepared by the method of Alastair Denholm (see Scheme 
4.3).106 Heating piperidine or pyrrolidine with 4-chlorobutyronitrile 
or 5-chlorovaleronitrile in dry butanol at reflux, in the presence of 
base and a catalytic amount of potassium iodide, produced the N- 
alkylated aminonitriles (149)-(154) in good yield. The nitriles were 
characterised by the nitrile stretching frequency in the IR spectra at 
2240 cm-1. Reduction by catalytic hydrogenation in aqueous acid over 
Adams' catalyst gave the saturated diamines. The iminium salts were 
obtained by mercuric acetate oxidation of the saturated diamines in 
aqueous acetic acid. In each case the product was obtained as a 
viscous gum which did not solidify. The iminium salts were 
characterised by NMR spectra showing signals around 6 8.5 for the 
imine proton. Synthesis of the seven membered cyclic iminium ions 
was attempted. The saturated diamines (119) and (120) were 
obtained in good yield, however oxidation with mercuric acetate 
returned only starting material. This is possibly due to the seven 
membered ring having to adopt an unfavourable conformation for 
imine formation.
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4.6c Results and Discussion
Using the peroxidase-coupled spectrophotometric assay105 the 
saturated compounds (1 15)-( 120) were tested as inhibitors of pea 
seedling diamine oxidase with cadaverine as the substrate. The 
results obtained obeyed Michaelis-Menten kinetics over inhibitor 
concentrations of 0.25 mM, 0.5 mM and 1.0 mM and were 
characteristic of competitive inhibition (see Table 4.3).
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n
+ Cl (CH2)mCN
BuOH
KI
K?CD,
80-90%
(ru^ 1. H2/P t02 
HO Ac
2. HC1(CH2)mCN
(149) n=l, m=2
(150) n=l, m=3
(151) n=2, m=2
(152) n=2, m=3
(153) n=3, m=2
(154) n=3, m=3 l.Hg(OAc)2,
(rH"' 5% HOAc
(115) n=l, m=2
(116) n=l, m=3
(117) n=2, m=2
(118) n=2, m=*3
(119) n=3, m=2
(120) n=3, m=3
(CH2)mCH2NH3+2Cr
H
120°C
2.HC1
(CH2)mCH2NH3+a
a
(54) n=l, m=2
(121) n=l, m=3
(122) n=2, m=2
(123) n=2, m=3
Scheme 4 .3 106
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Inhibitor Inhibitor Ki
Concentration
N-(4-Aminobutyl)pyrrolidinium 0.5 6.50
dihydrochloride (115) 1.0
N-(4-Aminobutyl)piperidinium 0.5
dihydrochloride (117) 1.0 8.50
N-(4-Aminobutyl)hexahydro- 0.5 0.27
azepinium dihydrochloride (119) 1.0 0.27
N-(5-Aminopentyl)pyrrolidinium 0.5 6.50
dihydrochloride (116) 1.0 4.30
N-(5-Aminopentyl)piperidinium 0.5 1.30
dihydrochloride (118) 1.0 1.86
N-(5-Aminopentyl)hexahydro- 0.5 0.52
azepinium dihydrochloride (120) 1.0 0.81
Table 4.3 Units; mM
It is clear from these results that the seven membered ring 
compounds (119) and (120) are better inhibitors of pea seedling DAO 
than the five and six membered ring compounds. Also, in the case of 
the six and seven membered ring compounds increasing the chain 
length causes a decrease in the inhibition. Therefore, increasing ring 
size appears to increase the inhibitory effect, on the other hand, 
increasing the substituent chain length causes the opposite effect. The
84
inhibition observed with N-(5-aminopentyl)piperidinium 
dihydrochloride (118) is not as great as that of the seven membered 
ring compounds although it is still significant. Compounds (115)-(l 17) 
showed no significant inhibition of pea seedling DAO.
The saturated amines with chain length between the two 
nitrogens the same as cadaverine were stronger inhibitors than those 
with four carbon atoms between the nitrogens as in putrescine. 
Further work is required to test the above compounds as inhibitors of 
pea seedling DAO with putrescine as the substrate.
The unsaturated compounds (54) and (121)-(123) were also 
tested as inhibitors of pea seedling diamine oxidase with cadaverine 
as the substrate. However, the results obtained did not obey 
Michaelis-Menten kinetics, therefore it was not possible to determine 
values for Km and Vmax. It was thought that the imines were in some 
way interfering with the assay in the production of hydrogen 
peroxide. If this is correct it may be possible to test these compounds 
by means of another assay system which does not involve the 
formation of hydrogen peroxide.
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4.7 Diamino Carbonvl Compounds as Inhibitors of Diamine 
Oxidase
4.7a Introduction
In 1973 Macholan compared the inhibitory effects of 1,4- 
diamino-2-butanone and l,5-diamino-3-pentanone.9-l The 3- 
ketocadaverine dihydrochloride (124) proved to be 14 times more 
potent a competitive inhibitor of pea seedling diamine oxidase, but a 
far weaker inhibitor of the animal enzyme than 2-ketoputrescine 
dihydrochloride (125), indicating that a p-amino-keto grouping plays a 
greater inhibitory role than an a-amino-keto group.
+ +
NH
2C1’2c r
(124)
The previous chapter contains a discussion of synthetic 
approaches to sparteine analogues. l,5-bis(Piperidyl)-3-pentanone 
dihydrochloride (91) and l,5-bis(hexahydroazepinyl)-3-pentanone 
dihydrochloride (94) are intermediates used in this work. It was 
thought that these diamino carbonyl compounds might be inhibitors of 
diamine oxidase and it would be of interest to see the effect of 
increasing substituent size rather than chain size. Although 
compounds (91) and (94) lack a primary amino group, and therefore 
are not expected to be substrates for diamine oxidase, they are 
substrate analogues and could still bind well to the enzyme. As 
discussed in Chapter 2 the pyrrolidine compound could not be 
synthesised.
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4.7b Results and Discussion
Both compounds (91) and (94) were initially tested as substrates 
of pea seedling diamine oxidase. No oxidation was observed in either 
case.
The compounds were then tested as inhibitors of pea seedling 
diamine oxidase with cadaverine as the substrate. Both compounds 
have five carbon atoms between the two nitrogens as in cadaverine. 
The results are shown in Table 4.4.
Inhibitor Inhibitor Kj
Concentration
1.5-bis(piperidyl)-3-pentanone 0.5 0.47
dihydrochloride (91) 1.0 0.38
1.5-bis(hexahydroazepinyl)-3- 0.5 0.35
pentanone dihydrochloride (94) 1.0 0.21
Table 4.4 Units: mM
Both compounds (91) and (94) assayed behaved as competitive 
inhibitors and obeyed Michaelis-Menten kinetics. As with the N- 
alkylated amines (115)-(120) discussed in the previous section the 
hexahydroazepinyl derivative (94) proved to be a better inhibitor 
than the six membered analogue. This suggests that the active site of 
the enzyme is relatively uncrowded to allow such large molecules to 
affect the rate of substrate oxidation so significantly.
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Macholan concluded that the keto group was essential for 
enzyme inhibition since catalytic hydrogenation of 1,5- 
diaminopen tan-3-one to the corresponding alcohol (126) resulted in 
the loss of its inhibitory properties.04 This appears to be true also for
1,5-bis(piperidyl)-3-pentanone (91). 1,5-bis(Piperidyl)-3-pentanol
(127) was prepared by sodium borohydride reduction in methanol of 
the diaminoketone (91) in quantitative yield. The alcohol (127) was 
tested as a substrate of diamine oxidase using the peroxidase-coupled 
assay system.105 No oxidation was observed. The compound (127) 
was then tested as an inhibitor with cadaverine as the substrate. No 
inhibition was observed at concentrations of 0.25, 0.5 and 1.0 mM of 
alcohol. This suggests that the inhibition may be due to interactions 
such as hydrogen bonding between the lone pairs of the carbonyl 
oxygen and the active site, or it may be due to the different geometry 
of the sp2 carbonyl and the sp3 hydroxy groups.
+ +
(126)
(127)
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4.8 D iam inobutenes as In h ib ito rs  o f D iam ine Oxidase
4.8a Introduction
It has been reported that l,4-diaminobut-2-ene is a substrate of 
diamine oxidase and undergoes oxidative deamination to yield 
pyrrole.107 It has also been shown to inhibit the enzyme at high 
concentration.107 It was thought to be of interest to compare both the 
cis- and trans-forms of analogues of l,4-diaminobut-2-ene (128)- 
(135) as potential inhibitors of diamine oxidase.
(12 8 )  2C1"
2C1'(130)
2Br(131)
(132)-(135): corresponding cis-isomers
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4.8b Synthesis o f  D iam inobutenes
The trans-diaminobutenes (128)-( 131) were prepared according 
to the method of Roberts et al. (Scheme 4.4).108 This involves the 
addition of eight equivalents of amine to a cooled concentrated 
solution of trans-1,4-dibromobut-2-ene to give the free base of the 
diamino product in good yields. The dihydrochloride salts were then 
formed by addition of aqueous HC1 to an organic solution of the free 
base. In the case of the di-pyrrolidyl compound (128), addition of 
aqueous HC1 resulted in the precipitation of a pale yellow hygroscopic 
solid. The salt was obtained more cleanly by adding diethyl ether 
saturated with dry HC1 gas to an ethereal solution of the free base. 
These compounds are characterised by a X2AA'X2' system in their 1H 
NMR spectra.
+
Br 1. Ph-H , 0°C, 
83-96%.
2. HC1
2C1‘
(128) n=l
(129) n=2
(130) n=3
+ n
Scheme 4 .4 108
trans-l,4-Dibromobut-2-ene in dichloromethane was added to 
two equivalents of cyclohexylamine at room temperature to form the
trans diaminobutene (131) directly as the hydrobromide salt (Scheme 
4.5).
The formation of the free base of (131) was attempted as for 
compounds (128)-(130) however this gave a mixture of products 
which was difficult to purify by fractional distillation. The method of 
formation of the dihydrobromide of (131) also gave a mixture of 
products but the salt was fairly easy to purify by crystallisation.
Br  v CH2Q2
rt. 18h.
4*
Br
(131)
2Br”
Scheme 4.5
Synthesis of the corresponding cis-compounds (132)-(135) was 
attempted using both the above methods with cis-l,4-dibromobut-2- 
ene (155) [prepared by treatment of cis-but-2-ene-l,4-diol with 
phosphorus tribromide] and cis-l,4-dichlorobut-2-ene. These 
methods yielded only the trans-compounds. This result is perhaps not 
surprising due to the bulky substituents. There is no evidence to 
suggest that a 1,4-elimination has taken place, since there is no 
terminal methylene signal visible in the lH NMR spectrum. However, 
since the double bond is already cis, it is surprising that no
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intramolecular reaction occurs after monosubstitution to form the 
quaternary ammonium salt.
4.8c Results and Discussion
Compounds (128)-(131) were initially tested as substrates of 
pea seedling diamine oxidase using the spectrophotometric assay.105 
No oxidation was observed in any case.
The compounds were then tested as inhibitors of pea seedling 
diamine oxidase with cadaverine as the substrate. The results are 
shown below (see Table 4.5).
Br Br
(155)
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Inhibitor Inhibitor Kj
Concentration
trans-l ,4-bis(pyrrolidyl)but-2-ene 0.25 3.75
dihydrochloride (128) 0.5 3.75
1.0 2.14
trans-l,4-bis(piperidyl)but-2-ene 0.25 0.32
dihydrochloride (129) 0.5 0.40
1.0 0.59
tra n s -l,4-bis(hexahydroazepinyl) 0.25
but-2-ene dihydrochloride (130) 0.5 6.0
1.0 1.09
trans-N,N'- bis(cyclohexyl)-l,4-but- 0.25 0.15
2-ene diamine dihydrobromide (131) 0.5 0.31
1.0 0.23
Table 4.5 Units: mM
Previously, in general, the compounds with seven membered 
rings were proving to be the better inhibitors, but it was thought that 
the introduction of a double bond which would reduce the flexibility 
of the chain would cause a significant change in inhibitory properties. 
Both compounds (128) and (130) were shown to be poor inhibitors, 
whereas, (129) was shown to inhibit more significantly. The 
arrangement of electron density around the nitrogens and the n 
electrons of the double bond may be favourable to the binding site. 
trans-N,N-bis(Cyclohexyl)-l,4-but-2-ene diamine (131) proved to be 
the best inhibitor of the four. This compound is similar in size and
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ring shape to (129) but has the probable added bonus of good binding 
to the enzyme through the more accessible secondary nitrogen.
4.9 Diaminobutanes as Inhibitors of Diamine Oxidase
4.9a Introduction
The obvious next step was to investigate the inhibitory 
properties of the saturated butanes corresponding to compounds
( 128)-( 131) to see the effect of increasing the chain flexibility. 
Compounds (136)-(139) were synthesised from the butenes (128)-
(131) to be tested as inhibitors of pea seedling diamine oxidase.
(136) 2d
(138) 2Q.
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4.9b Synthesis o f D iam inobutanes
The double bond was reduced in all cases, in good yields, by 
hydrogenation of the dihydrochloride or dihydrobromide salt in 
methanol in the presence of palladium on charcoal (Scheme 4.6).
Scheme 4.6
4.9c Results and Discussion
Compounds (136)-(139) were tested as substrates of pea 
seedling diamine oxidase using the spectrophotometric assay.105 No 
oxidation was observed.
Compounds (136M 139) were then examined as inhibitors of 
diamine oxidase with cadaverine as the substrate. The results are 
shown in Table 4.6. Assays in the presence of these compounds 
obeyed Michaelis-Menten kinetics and were characteristic of 
competitive inhibition.
H2/Pd-C/MeOH 
r t , 2h
(137) 2C1-
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Inhibitor Inhibitor K*
Concentration
1.4-bis(pyrrolidyl)butane 0.5 1.07
dihydrochloride (136) 1.0 0.94
1.4-bis(piperidyl)butane 0.5 0.90
dihydrochloride (137) 1.0 1.25
1.4-bis(hexahydroazepinyl) 0.5 0.35
butane dihydrochloride (138) 1.0 0.54
N,Nr-bis(cyclohexyl)- 1,4-butane 0.5 0.62
diamine dihydrobromide (139) 1.0 0.54
Table 4.6 Units: mM
These results show that again the seven membered ring 
compound (138) is the best inhibitor in the comparison of ring sizes. 
However, the inhibition shown by N,N-bis(cyclohexyl)- 1,4-butane 
diamine (139) is also significant.
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4.10 D iam inobutvnes as In h ib ito rs  o f  D iam ine Oxidase
4.10a Introduction
It has been reported that l,4-diaminobut-2-ene is a mechanism- 
based inhibitor of pea seedling diamine oxidase. 109 Following on from 
these studies it was decided that the next target molecules should be 
the corresponding butyne analogues. Compounds (140)-(143) were 
synthesised to be tested as inhibitors of diamine oxidase.
/ H
(141) 2C1'
(1 4 0 )  2C1'
(143) 2cr
(142) 2Q"
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4.10b Synthesis o f D iam inobutvnes
Compounds (141)-(143) were synthesised following the method 
of Biel et a l (Scheme 4.7).110 Four equivalents of the amine were 
added to cooled, neat l,4-dichlorobut-2-yne to give the products in 
the form of the free base in excellent yields. Previous experience has 
shown that pyrrolidyl compounds tend to be hygroscopic and are 
difficult to extract from aqueous solution. The method of Roberts et a l 
108 used previously for the synthesis of the butenes was adapted for 
the preparation of l,4-bis-(pyrrolidyl)but-2-yne (140). Subsequent 
treatment with dry HC1 gas in diethyl ether gave the dihydrochloride 
salt in 98% yield.
I (CH2)n
a
H 0°C , 15 min
(141) n=2
(142) n=3
H/ / " -''(C H 2)
2C1
Scheme 4.7*10
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4.10c Results and Discussion
Compounds ( 140)-( 143) were tested as substrates of pea 
seedling diamine oxidase. No oxidation was observed.
The butynes ( 140)-( 143) were then assayed as inhibitors of 
diamine oxidase with cadaverine as the substrate. All obeyed 
Michaelis-Menten kinetics and data were characteristic of competitive 
inhibition. The results are shown in Table 4.7
Inhibitor Inhibitor Ki
Concentration
1.4-bis(pyrrolidyl)but-2-yne 0.5 2.50
dihydrochloride (140) 1.0 1.15
1.4-bis(piperidyl)but-2-yne 0.5 3.75
dihydrochloride (141) 1.0 1.87
1.4-bis(hexahydroazepiny 1) 0.5 1.17
but-2-yne dihydrochloride (142) 1.0 1.07
N,N'-bis(cyclohexyl)-l,4-but-2-yne 0.5 0.37
diamine dihydrobromide (143) 1.0 0.39
Table 4.7 Units: mM
These results show that N,N-bis(cyclohexyl)-l,4-but-2-yne 
diamine (143) was the best inhibitor of the butynes tested. This may 
again be due to a favourable arrangement of the n electrons of the
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triple bond and the charge density around the two nitrogen atoms for 
the active site. Reducing the degrees of freedom in the chain has 
decreased the inhibitory properties of the seven membered ring 
compound (142).
4.11 Di-N-Alkvlated Diamines as Inhibitors of Diamine 
Oxidase
4.11a Introduction_____
l,6-bis(Piperidyl)hexane dihydrobromide (144) is a compound 
which is easily synthesised111 and has previously been tested as an 
inhibitor of diamine oxidase.112 Although not a particularly good 
inhibitor, it was thought that the di-iminium salt (145) might be a 
good inhibitor if it obeyed Michaelis-Menten kinetics, unlike the 
previous imines (54) and (121)-(123) tested. 1,6-
bis(Piperidyl)hexane (144) and its di-iminium salt (145) were 
synthesised to be tested as inhibitors of pea seedling diamine oxidase. 
Attempts were also made to synthesize the corresponding pyrrolidine 
analogues.
H
(144)
a
(145)
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4.11b Synthesis
l,6-bis(Piperidyl)hexane (144) was formed by the addition of 
piperidine to an aqueous solution of 1,6-dibromohexane (Scheme 
4.8).111 Synthesis of l,6-bis(pyrrolidyl)hexane was attempted in the 
same manner but gave a brown tar from which the product could not 
be crystallised. This is not surprising due to previous results when 
using pyrrolidine in aqueous conditions.
(25) I H20 ,1 2 0 °C ,6 h .
(144)
Scheme 4 .8 111
The di-iminium salt (145) was synthesised from pipecolic acid 
and 1,6-dibromohexane (Scheme 4.9). The methyl ester of pipecolic 
acid (156) was prepared to protect the amino acid carboxyl function. 
Treatment of the diester product (146) with aqueous hydrochloric acid 
to hydrolyse the ester groups to give (157) was followed by 
phosphorus oxychloride to complete decarbonylation. The lH NMR 
spectrum of (145) showed a broad singlet at 6 8.45 for the imine 
proton Despite attempted purification using a chloride ion-exchange
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column, the product was too contaminated with phosphate ions to be 
tested as an inhibitor of diamine oxidase.
Synthesis of the corresponding pyrrolidyl compound was 
attempted using methyl prolinate and 1,6-dibromohexane. Under 
various reaction conditions, involving slow addition of the amino ester 
to the alkyl dibromide to avoid diketopiperazine formation, the 
product was not formed. This precaution would however be negated 
by the long reaction time required for substitution to occur.
4.12 Conclusions
It is apparent from these results that the most effective 
inhibitors of pea seedling diamine oxidase, from the compounds 
tested, were those containing a p-amino keto moiety or a secondary 
amine substituent. Time constraints prevented the synthesis and 
testing of other potential inhibitors such as N,N'-bis(cyclohexyl)- 
pentan-3-one-l, 5-diamine (147). Further investigation is 
recommended into compounds of this type.
(147)
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-CD,Me
(156)
Ph-H , K2CD3 , KI 
70°C, 6&
MeO
(146)
1. 6M HC1, 80 °C , 24H.
(D2H
HO
2C1'
(157)
2. P0C13 , 3min , 110°C
(145)
Scheme 4.9
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CHAPTER 5
EXPERIMENTAL
5.1 General
Melting points were measured on a Kofler hot-stage 
apparatus, and boiling points refer to the oven temperature using 
a Kugelrohr apparatus. Infra red spectra (IR) were obtained on a 
Perkin Elmer 580 spectrometer. Nuclear magnetic resonance 
spectra (NMR) were recorded on a Perkin Elmer R32 
spectrophotometer operating at 90 MHz, or a Bruker WP200-SY 
spectrophotometer operating at 200 MHz (5h) or 50.3 MHz (8c). 
The multiplicities of the 13C NMR spectrum were determined using 
DEPT spectra with pulse angles of 0 -  90° and 0 = 135°. Spectra 
were recorded with either tetramethylsilane at 0 ppm or the NMR 
solvent as the internal standard. Mass spectra were obtained 
using A.E.I. MS 12 or 902 spectrometers. Elemental analyses were 
obtained with a Carlo-Erba 1106 elemental analyser.
Thin layer chromatography (TLC) was carried out on Merck 
Kieselgel G plates of 0.25 mm thickness in chloroform-methanol- 
ammonia (85:14:1) unless otherwise stated. Secondary amines 
were detected with ninhydrin, tertiary amines with DragendorfFs 
reagent and all other compounds with iodine or by ultra violet 
radiation (UV).
All solvents were purified by standard techniques. H3 
Tetrahydrofuran (THF) and diethyl ether were dried by 
distillation from sodium-benzophenone under nitrogen 
immediately before use.
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5.2 Experimental to Chapter 2
General Procedure for Complex Formation with 1-Pvrroline
4-Aminobutanal diethylacetal (5) (2.34 g, 14.5 mmol) 
was dissolved in 2M HC1 (20 ml) and diethyl ether (50 ml) was 
added. The mixture was stirred at 0 °C for 20 min, then basified 
with potassium carbonate. The aqueous layer was extracted with 
cold diethyl ether (3 x 50 ml). The combined organic extracts 
were cooled to 0 °C, dried, filtered and the zinc or cadmium 
dihalide (0.5 equivalent) was added. Each mixture was stirred at 
0 °C for 30 min. The precipitate was filtered off and washed well 
with diethyl ether and hexane leaving a solid which was 
recrystallised from chloroform and hexane.
bis(3.4-Dihvdro-2 ff-pvrrol-1 -vDdi-iodozinc (66147
The zinc iodide was flame-dried under vacuum before 
use. The product (66) was obtained as white crystals (2.0 g, 61%), 
m.p. 203-205 °C; vmax (KBr disc) 2970, 1635, 1330, 960, 925 and 
420 c m -l;  6h (200 MHz) [(CD3)2CO] 1.99-2.15 (4H, complex, 4 -H2), 
2.89-2.98 (4H, complex, 3-H2), 3.94-4.05 (4H, complex, 5 -H2) and 
8.26 (2H, m, 2-H); 8C(50 MHz) [(CD3)2CO] 20.7 (t, CM), 37.4 (t, C-3),
59.9 (t, C-5) and 178.6 (d, C-2). (Found: C, 20.94; H, 2.84; N, 6.01; 
1,55.56; Zn,14.86%. C g H ^ ^ Z n  requires C, 21.00; H, 3.09; N, 6.12; 
I, 55.49; and Zn, 14.29%.). Spectroscopic data were identical to 
those reported by G. Baxter.47
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bis(3,4-Dihvdro-2 H -pvrrol-1 -vDdichlorozinc (67)
This was obtained as a white solid (67) (0.37 g, 18%), 
m.p. 135-140 °C; vmax (KBr disc) 2970, 1635, 1330, 960, 925 and 
420 cm*1; 8H (200 MHz) [(CD3)2CO] 1.94-2.10 (4H, complex, 4-H2), 
2.83-2.94 (4H, complex, 3-H2), 3.88-3.99 (4H, complex, 5-H2) and 
8.11 (2H, m, 2-H); 8C(50 MHz) [(CD3)2CO] 20.6 (t, C-4), 37.2 (t, C-3),
59.9 (t, C-5) and 177.9 (d, C-2). (Found: C, 34.80; H, 4.81; N, 9.98%. 
Q H i4N2Q2Zn requires C, 35.00; H, 5.14; and N, 10.20%.)
bis( 3.4-Dihvdro-2H-pyrrol-1 -vPdibromozinc (68)
This was obtained as a yellow solid (68) (0.46 g, 17%), 
m.p. 162-165 °C; vmax (KBr disc) 2960, 1635, 1330, 960, 925 and 
420 cm*1; 6H (200 MHz) [(CD3)2CO] 1.96-2.12 (4H, complex, 4-H2), 
2.85-2.96 (4H, complex, 3-H2), 3.90-4.02 (4H, complex, 5-H2) and 
8.16 (2H, m, 2-H); 8C(50 MHz) [(CD3)2CO] 20.6 (t, C-4), 37.3 (t, C-3),
59.9 (t, C-5) and 178.2 (d, C-2). (Found: C, 26.35; H, 3.38; N, 7.52; 
Br, 44.33; Zn, 18.42%. C8Hi4N2Br2Zn requires C, 26.44; H, 3.88; N, 
7.71; Br, 43.97; and Zn, 18.00%.)
bis(3.4-Dihvdro-2//-pvrrol-l-vDdi-iodocadmium (69)
This complex was precipitated by the addition of 
cadmium iodide (5.31 g, 14.5 mmol, 1 equivalent) to the dried 
ethereal extracts. Recrystallisation from acetone gave the complex 
(69) as white crystals (1.26 g, 20%), m.p. 108-109 °C; vmax (KBr 
disc) 2950, 1625, 1330, 955, 920 and 415 cm*1; 8H (200 MHz) 
[(CD3)2CO] 1.98-2.06 (2H, complex, 4-H2), 2.84-2.96 (2H, complex,
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3-Hzl, 3.93-4.05 (2H, complex, 5-H2) and 8.17 ( 1H, m, 2-H); 5C (50 
MHz) [(CD3)2CO] 20.3 (t, C-4), 37.2 (t, C-3), 60.5 (t, C-5) and 178.0-
178.2 (s, C-2). (Found: C, 11.20; H, 1.53; N, 3.37; I, 58.58; Cd, 
25.32%. CqHyN^Cd requires C, 11.04; H, 1.62; N, 3.22; I, 58.30; and 
Cd, 25.82%.)
Preparation of Norhvgrine (70)47
bis(3,4-Dihydro-2//-pyrrol-l-yl)di-iodozinc (6 6 ) (0.97 g,
2.13 mmol) in methanol (50 ml) and 1M phosphate buffer (pH 7, 4 
ml) were added to a solution of acetoacetic acid (0.5 g, 4.9 mmol) 
in water (10 ml) and the pH was adjusted to 7 with 1M KOH. The 
mixture was stirred at room temperature for 60 h then acidified 
with 2M HC1 and heated at reflux for 3 h. The cooled solution was 
washed with diethyl ether (3 x 50 ml), and saturated with solid 
potassium carbonate. The basic solution was extracted with 
chloroform (3 x 80 ml). The combined organic extracts were 
dried, filtered and concentrated to yield norhygrine (70) as an 
unstable oil (0.30 g, 55.6%), Rf 0.52 (n-BuOH/acetic acid, 4:1, 
saturated with water); vmax (CHCI3) 2940, 1700 and 1535 cm*1; 6h 
(90 MHz) 1.3-3.8 (10H, complex) and 2.20 (3H, s, CH3-).
Preparation of 3.4-Dimethoxvbenzovl Chloride (73)52
3,4-Dimethoxybenzoic acid (74) (5 g, 0.027 mol) in 
thionyl chloride (5 ml) was heated at reflux overnight. The excess 
thionyl chloride was removed by concentration under reduced 
pressure leaving the acid chloride (73) in quantitative yield (The 
excess thionyl chloride was quenched with NaHCQ3). The acid
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chloride was used immediately in the next stage; m.p. 73-75 °C; 8n 
(CDCI3) 4.00 (6H, 2s), 6.95 (1H, d, J 9  Hz), 7.55 (1H, br s) and 7.85 
(1H, d with fine splitting, J 9 Hz).
Preparation of Ethvl 3.4-Dimethoxvbenzovlacetoacetate (75)^
The acid chloride (73) (5.45 g, 0.0272 mol) in anhydrous 
THF (40 ml) was added drop wise with good mixing to a 
suspension of ethyl acetoacetate (10.66 g, 0.0815 mol) and sodium 
(1.64 g, 0.0713 mol) in anhydrous THF (75 ml) under a nitrogen 
atmosphere. The solution was heated at reflux for 5 h and left to 
stand overnight. The precipitate formed was filtered and washed 
with diethyl ether. The sodium salts were dissolved in cold water 
(1.5 1) and decomposed with 10% hydrochloric acid. The diketo 
ester separated as an oil which was extracted with diethyl ether. 
The combined organic extracts were dried, filtered and 
evaporated to dryness under reduced pressure to yield the 
product (75) (6.90 g, 86%), m.p. 79-80 <>Q vmax (CHCI3) 2980, 
1740, 1710, 1670, 1595, 1510, 1460, 1270, and 1150 cm*l; 8H 
(CDCI3) 1.15 (3H, t), 2.40 (3H, s), 3.98 (6H, 2s), 4.17 (2H, q), 5.35 
(1H, s), 6.92 (1H, d), 7.30 (1H, br s) and 7.50 p.p.m. (1H, d with 
fine splitting); m /z  295 (M++  1), 294 (M -*), 248 and 165 (100 %).
Preparation of Ethvl 3.4-Dimethoxvbenzovlacetate (76)52
Ethyl 3,4-dimethoxybenzoylacetoacetate (75) (6.89 g, 
0.023 mol) was dissolved in aqueous ethanol (90%, 30 ml). To this 
solution sodium acetate (96 mg, 1.17 mmol) was added and the 
mixture was heated at 100 °C for 6 h. After a long period of
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cooling the product (76) crystallised out of solution in quantitative 
yield; m.p. 44-45 °C; vmax (CHCI3) 3020, 2940, 2840, 1735, 1680, 
1600, 1510, 1420, 1270, 1150 and 1025 cnr*; 8H (CDCI3) 1.30 (3H, 
t, J7 Hz), 4.00 (6H, s), 4.25 (2H, q ,J7H z), 6.90 (1H, d ,J 9  Hz), 7.56 
(1H, br s) and 7.65 (1H, d with fine splitting); m /z  253 (M ++  1), 
252 (M+), 165 (100 %) and 137.
Preparation of 3.4-Dimethoxvbenzovlacetic Acid (72)52
This stage was not carried out until 2 d before the acid 
was required. The £-keto acid decarboxylates readily.
Ethyl 3,4-dimethoxybenzoylacetate (76) (2.02 g, 8.0 
mmol) in 2.5% aqueous potassium hydroxide (140 ml) was stirred 
for 48 h at room temperature. The solution was then washed with 
diethyl ether (3 x 40 ml), acidified at 10 °C with 2M sulphuric acid 
and extracted with diethyl ether (5 x 50 ml). The combined 
organic extracts were dried (MgSO.4), filtered and evaporated to 
dryness under reduced pressure at room temperature to yield
3,4-dimethoxybenzoylacetic acid (72) (1.57 g, 87%) which was 
stored at < 0  °C; m.p. 29 °C (decarb.); 5h (CDCI3) 3.92 (6H, 2s), 4.02 
(2H, s), 6.95 (1H, d, J 9  Hz), 7.55 (1H, br s) and 7.65 (1H, d with 
fine splitting).
Preparation of Ruspolinone (71)
bis(3,4-Dihydro-2//-pyrrol-1-yl)di-iodozinc (6 6 ) (0.91 g, 
1.98 mmol) in methanol (60 ml) and 1M phosphate buffer (pH 7, 5 
ml) was added to a solution of 3,4-dimethoxybenzoylacetic acid
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(72) (1.12 g, 5 mmol, 2.5 equivalents) in water (12 ml) and the pH 
was adjusted to 7 with 1M potassium hydroxide. The mixture was 
stirred at room temperature for 48 h then acidified with 2M 
hydrochloric acid to pH 2 and heated at reflux for 3 h. The cooled 
solution was washed with diethyl ether (3 x 50 ml), saturated 
with solid potassium carbonate and then extracted with 
chloroform (3 x 100 ml). The combined organic extracts were 
dried, filtered and evaporated to dryness to yield ruspolinone 
(0.91 g, 92%). The product (71) was purified (81%) by preparative 
TLC on silica gel and elution with CHQ3-MeOH-conc. ammonia 
(85:14:1), RF 0.23; vmax (KBr disc) 3430, 2930, 1670, 1640, 1600, 
1260, 1145 and 1020 cnrl; 6H (200 MHz) (CDC13) 1.41-2.10 (4H, 
complex, 3-and4-H2), 2.96 (2H, m, 5-H2), 3.21 (2H, d, J 6  Hz, 6 -H?),
3.5 (1H, br s, NH), 3.57-3.74 (1H, m, 2-H), 3.90 (3H, s), 3.92 (3H, s), 
6.84 (1H, d, J 9 Hz, 12-H), 7.49 (1H, d, J2  Hz, 9-H), 7.56 (1H, dd, J 9  
and 2 Hz, 13-H); 6C (50 MHz) (CDCI3) 24.5 (t, C-4), 31.2 (t, C-3),
43.8 (t, C-6 ), 45.9 (t, C-5), 55.0 (d, C-2), 55.9 and 56.0 (2q, C-14 
and -15), 110.0 (2d, C-9 and -12), 122.9 (d, C-13), 130.1 (s, C-8 ),
149.0 (s, C-10), 153.3 (s, C - l l)  and 198.0 (s, C-7); m /z  249 (M*0, 
180, 165, 137, 77 and 70 (100%). (Found: M+ 249.1356. 
Q 4H19O3N requires 249.1365). Spectroscopic data were identical 
to those reported.50
Attempted Formation of Complex with 1-Piperideine (4)
Usine L-Lvsine Monohvdrochloride53
L-Lysine monohydrochloride (0.184 g, 1 mmol) was 
dissolved in water (20 ml) and freshly crystallised N-
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bromosuccinimide (0.356 g, 2 mmol) was added to the solution. 
The mixture was rotated on a rotary evaporator under mild 
suction at 40 °C until colourless (ca. 15 min). The solution was 
basified with aqueous potassium carbonate (20% w/v, 4 ml) and 
then extracted with cold diethyl ether (3 x 1 0  ml). The combined 
organic extracts were washed with water (3 x 30 ml), dried, 
filtered and zinc iodide (0.482 g, 1.6 mmol) was added. The 
mixture was stirred at 0 °C for 30 min. No complex was formed.
The reaction was repeated in the absence of zinc iodide. 
The dried ethereal extracts were evaporated to dryness at room 
temperature leaving a clear oil (0.095 g). A small portion of the 
oil was dissolved in 2M hydrochloric acid. TLC (silica gel, n- 
BuOH/HOAc/water, 2:1:1) showed the presence of 1-piperideine 
(4) (Rf 0.50) as the major component, together with traces of 
unreacted L-lysine (51) (0.22); 5h (D2O) 7.5 (s), 6.9 (s), 6.3 (s), 3.5 
(br m), 3.0 (m) and 2.6 (s, [CH2CDI2NH, succinimide).
Preparation of a-Tripiperideine (79)US
Freshly distilled piperidine (5 ml, 50.6 mmol) was 
added by syringe to a stirred suspension of N- chlorosuccinimide 
(12.0 g, 89.9 mmol) in anhydrous diethyl ether (250 ml) at room 
temperature. Stirring was continued for 90 min. The mixture was 
then filtered directly into a dropping funnel and added dropwise 
over 1 h to a stirred solution of potassium hydroxide (3 g, 53.5 
mmol) in ethanol (30 ml) at 70 °C. The mixture was stirred at 70 
°C for 2 h then left to stand at room temperature overnight. The 
precipitate formed was filtered off and the filtrate was
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evaporated to dryness under reduced pressure leaving a yellow 
solid (3.36 g, 80%). Recrystallisation from acetone yielded the 
product (79) as yellow crystals (3.0 g, 71%), m.p. 60 °C (lit.,115 59- 
61 °C); Rf 0.52; vmax (KBr disc) 2930, 2850, 1455, 1240 and 1150 
cm*1: 8h (200 MHz) (CDC13) 1.25-2.30 (12H, complex), 2.20 (6H, m), 
2.87 (3H,m), 3.05 (3H, m) and 3.50 (3H, m); 8C (50 MHz) [(CD3)2(D]
23.0 (t, C-4), 26.6 (t, C-5), 29.8 (t, C-3), 46.9 (t, C-6 ) and 82.6 (d, C-
2); m /z  249 (M*9, 83, 68 , 55 (100%) and 41. (Found: C, 72.12; H, 
10.79; N, 16.76%. C15H27N3 requires C, 72.29; H, 10.84; N, 16.87%.)
Using ft-Tripiperideine (79)
Cone, hydrochloric acid (0.5 ml) was added slowly to a- 
tripiperideine (79) (0.5 g, 2 mmol) at -20 °C and then water (16.5 
ml) was added. The solution was basifled with conc. ammonia 
then extracted with cold diethyl ether (3 x 20 ml). The combined 
organic extracts were then dried, filtered, and zinc iodide (1.9 g, 6 
mmol) was added and the solution was stirred at 0 °C for 30 min. 
No complex was formed.
Using Piperidine
A solution of piperidine (0.45 ml, 4.5 mmol) and 
triethylamine (1.89 ml, 13.6 mmol) in dry CH2Q2 (7 ml) was 
cooled to 0 °C and N-bromosuccinimide (1.34 g, 7.5 mmol) was 
added with stirring. After 30 min triethylamine (5.65 ml, 40.7 
mmol) was added. After 16 h in a slowly warming ice bath, the 
mixture was extracted with cold 1M hydrochloric acid (3 x 1 5  ml). 
Potassium iodide (0.5 g, 3.0 mmol) and sodium thiosulphate (1 g)
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were added to the solution which was then basified with conc. 
ammonia and extracted with cold diethyl ether (3 x 50 ml). The 
combined organic extracts were dried, filtered and evaporated 
under reduced pressure leaving a mixture of products; 5h (CDCI3) 
no CH=N.
Using Pipecolinic Acid
Pipecolinic acid (0.258 g, 2 mmol) was stirred at 100 °C 
with phosphorus oxychloride (18 ml, 20 mmol) for 3 min. The 
solution was then cooled and water (20 ml) was added very 
slowly. The solution was then saturated with solid potassium 
carbonate and extracted with diethyl ether (3 x 20 ml). The 
combined organic extracts were dried, filtered and evaporated to 
dryness under reduced pressure leaving a yellow solid (0.028 g); 
5h (CDQ3) no CH=N; all spectral properties were identical to a- 
tripiperideine.
Preparation of lodosobenzene (148)56
3M Sodium hydroxide (50 ml) was added over 5 min 
with vigorous stirring to finely ground iodosobenzene diacetate 
(10.7 g, 0.033 mol) at room temperature. The solid formed was 
broken up using a stirring rod and then the mixture was left to 
stand for 45 min. Water (35 ml) was added and the mixture was 
stirred vigorously for 30 min. The crude solid was filtered off and 
triturated with water (65 ml). The solid was again filtered, 
washed well with water and then triturated with chloroform (25
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ml). The product was then filtered off and dried leaving a yellow 
solid (148) (6.47 g, 88.5%); m.p. 210 °C (explosive) (lit.,56 210 °C).
Using lodosobenzene (148) and Piperidine
Iodosobenzene (148) (0.83 g, 3.76 mmol), crushed
molecular sieves and anhydrous dichloromethane (10 ml) were 
stirred together at in a round-bottomed flask equipped with 
reflux condenser and drying tube containing Drierite. Piperidine 
(0.43 ml, 3.76 mmol) was added and the mixture was stirred for 1
h at 0 °C. The mixture was then filtered and the filtrate was
transferred to a flask containing zinc iodide (0.51 g, 1.6 mmol). 
The mixture was stirred at 0 °C for 30 min. No complex was 
formed. In the absence of zinc iodide the organic solution was 
evaporated under reduced pressure. &h (CDC13) No CH=N.
Using Iodosobenzene (148) and Pipecolic acid
lodosobenzene (148) (0.81 g, 3.68 mmol), crushed
molecular sieves and anhydrous dichloromethane (10 ml) were 
stirred together at in a round-bottomed flask equipped with 
reflux condenser and drying tube containing Drierite. Pipecolinic 
acid (0.475 g, 3.68 mmol) was added and the mixture was stirred 
for 24 h at room temperature. The mixture was then filtered and 
the filtrate was transferred to a flask containing zinc iodide (1.18 
g, 3.7 mmol). The mixture was stirred at 0 °C for 30 min. No 
complex was formed. In the absence of zinc iodide the organic 
solution was evaporated under reduced pressure. 6h (CDC13) No 
CH=N.
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Preparation o f Pelletierine (82^
1-Piperideine (4) [from L-lysine monohydrochloride 
(0.046 g, 0.25 mmol) and N- bromosuccinimide (0.089 g, 0.5 
mmol) in water (5 ml)] was added dropwise over 24 h to a 
solution of lithium acetoacetate (0.106 g, 1 mmol) in 1M 
phosphate buffer (pH 7, 2.5 ml) at room temperature under 
nitrogen. The dropping funnel was washed with water (0.5 ml) 
and the washings were allowed to drop into the reaction mixture. 
The mixture was then cooled to 5 °C, saturated with solid 
potassium carbonate and extracted with chloroform (3 x 10 ml). 
The combined organic extracts were dried, filtered and 
evaporated to dryness leaving a clear oil (0.032 g, 90%). The 
product (82) was purified (68%) by preparative TLC on silica gel, 
RF 0.46; vmax (CHCI3) 3490, 2940, 1720, 1590, 1265, 1170 and 
920 cm-1; 8H (200 MHz) (CDCI3) 1.54-L85 (6 H, complex, 3-, 4- and 
5 - H 2), 2.14 (3H, s, 9 -H3), 2.70 (2H, m, 6 -H2), 2.79 (2H, d, J 6  Hz, 7- 
H?), 3.12 (2H, m, 2-H and NH); 8C (50 MHz) (CDCI3) 23.6 (t, C-4),
24.3 (t, C-5), 30.5 (q, 0 9 ) , 30.6 (t, 0 3 ), 46.0 (t, 0 7 ) , 48.6 (t, 0 6 )  
and 56.2 (d, 0 2 ); m /z  141 (Af*), 126, 98, 84, 56, 43 and 28 
(100%).
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Preparation of 3*. 4 ,-Dimethoxv-2,-(2-piperidvI)acetophenone (31)
1-Piperideine (4) [from L-lysine monohydrochloride 
(0.092 g, 0.5 mmol) and N-bromosuccinimide (0.18 g, 1 mmol) in 
water (10 ml)] was added dropwise over 24 h to a solution of 3,4- 
dimethoxybenzoylacetic acid (72) (0.22 g, 1 mmol) in 1M 
phosphate buffer (pH 7, 6  ml) at room temperature under 
nitrogen. The dropping funnel was washed with water (1 ml) and 
the washings were added to the reaction mixture. The mixture 
was then cooled to 5 °C, basified with cold 10% potassium 
hydroxide and extracted with chloroform (3 x 10 ml). The 
combined organic extracts were dried, filtered and evaporated to 
dryness leaving a yellow oil (0.141 g). The product (31) was 
purified (70%) by preparative TLC on silica gel and elution with 
CHQ3-MeOH-conc. ammonia (85:14:1), Rf 0.49; vmax (CHC13) 3440, 
2940, 1675, 1635, 1600, 1265, 1150 and 1020 cnrl; 6H (200 MHz) 
(CDQ3) 1.25-1.82 (6H, complex, 3-, 4- and 5 -H 2), 2.72 (2H, m, 6 - 
H2 ), 2.98 (2H, d, J 6  Hz, 7 -H2), 3.5 (1H, br s, NH), 3.10 (1H, m, 2-H), 
3.91 (3H, s), 3.92 (3H, s), 6.85 (1H, d, J9  Hz, 12-H), 7.49 (1H, d, J  2 
Hz, 9-H), 7.59 (1H, dd, 7 9 and 2 Hz, 13-H); 8C (50 MHz) (CDCI3)
25.9 (t, C-4), 29.7 (t, C-5), 32.8 (t, C-3), 45.0 (t, C-7), 46.6 (t, C-6 ),
53.2 (d, C-2), 55.9 and 56.0 (2q, C-15 and -16), 110.0 (d, C-10 and 
-13), 122.9 (d, C-14), 130.3 (s, C-9), 149.0 (s, C -ll) ,  153.4 (s, C-12) 
and 198.0 (s, C-8 ); m /z  264 (M++ 1), 263 (Af9, 180, 165 (100%), 
137, 84 and 55. (Found: M+ 263.1515. C 15H 21Q 3N  requires
263.1521.). Spectroscopic data are in accordance with literature 
values. I5
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Preparation o f 2.4-Pentadienoic Acid (87)59
Acrolein (10 ml, 0.15 mol) was added dropwise over 15 
min to malonic acid (25 g, 0.24 mol) in pyridine (35 ml) at 80 °C 
After 15 min stirring another portion of acrolein (10 ml, 0.15 mol) 
was added. The solution was then cooled and quenched by adding 
to ice (150 g), rinsing the reaction flask with CH2Q2 (50 ml). The 
mixture was acidified with conc. sulphuric acid (17.5 ml) at 0 °C 
The layers were then separated and the aqueous layer was 
extracted with more CH2Q2 (3 x 50 ml). The combined organic 
extracts were dried, filtered and evaporated under reduced 
pressure. The residue was washed with ice/water (10 ml), 
filtered, dissolved in water (70 ml) containing hydroquinone (0.15 
g) at 75 °C, cooled, filtered and dried in  vacuo. The product (87) 
was obtained as white crystals (7.7 g, 53%); m.p. 71-72 °C ( lit59, 
71.5-72.5 °C);RF 0.57 [EtOAc-HOAc, (9:1)]; vmax (KBr disc) 3100- 
2400, 2930, 1690, 1640, 1600, 1445, 1380, 1240, 1105, 1115, 
970, 960 and 800 cm-l; 6H (200 MHz) 5.47-5.72 (2H, ABCDD' 
system, J sa 10 .0 2 , 1.65, 0.82 and 0.71, J SB 16.98, 1.65, 0.81, 0.76, 
5A and 5B-H), 5.92-6.00 (H, ABCDD* system, J  15.40, 0.81, 0.72 
and 0.71, 2-H), 6.47-6.61 (H, ABCDD* system, J  16.98, 10.88, 10.02 
and 0.72, 4-H) and 7.19-7.32 (H, ABCDD* system, J  15.40, 10.88, 
0.82 and 0.76, 3-H); (CDCI3) 8C (50 MHz) (CDCI3) 123.13 (d, C-2), 
125.93 (t, C-5), 135.81 (d, C-4), 145.80 (d, C-3) and 168.07 (s, C- 
1); m /z  99 (M++ 1), 98 (M+), 97, 81, 70, 69, 55, 53, 52, 51, 50, 42, 
.4 1 ,2 8 , 27(100%) and 18.
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Preparation o f Methvl 2.4-Pentadienoate (78)5C)
2,4-Pentadienoic acid (87) (4.0 g, 0.041 mol) partially 
dissolved in ether (150 ml) was treated with an excess of 
diazomethane at 0 °C Nitrogen gas was bubbled gently through 
the solution for 2 h and then aqueous acetic acid (5% v/v, 10 ml) 
was added. The organic layer was separated, washed with 
aqueous sodium bicarbonate (5% w/v, 100 ml) and water (100 
ml), dried (MgSC>4), filtered and evaporated under reduced 
pressure to leave a pale yellow oil which was purified by 
distillation. The product (78) was obtained as a clear oil (2.0 g, 
44%); b.p. 76 <>C (20 mmHg); RF 0.56 (Et2 0 ); v max (CHCI3 ) 3010, 
2950, 1715, 1645, 1600, 1440, 1275, 1150, 1115, 965, 930 and 
870 cm*1; 6H (200 MHz) (CDCI3) 3.69 (3H, s, COOCH3), 5.49-5.73 
(2H, ABCDD' system, J  s a  10.02, 1.65, 0.82 and 0.71, J 5b 16.98, 
1.65, 0.81, 0.76, 5A and 5B-H), 5.94-6.02 (H, ABCDD' system, J  
15.40, 0.81, 0.72 and 0.71, 2-H), 6.45-6.62 (H, ABCDD’ system, J  
16.98, 10.88, 10.02 and 0.72, 4-H) and 7.18-7.31 (H, ABCDD' 
system, J  15.40, 10.88, 0.82 and 0.76, 3-H); 8C (50 MHz) (CDCI3)
51.62 (q, -CH3), 122.70 (d, C-2), 126.08 (t, C-5), 135.77 (d, C-4), 
145.44 (d, C-3) and 167.25 (s, C-l); m /z  113 (M++ 1), 112 (M+), 
111, 97, 81, 79, 67, 55.5, 54.5, 53.5 (100%), 52, 51, 50, 43, 41, 28 
and 27.
Preparation of Methvl 1.2-Didehvdro-quinolizidine-l-carboxvlate
IM158
a-Tripiperideine (79) (0.60 g, 2.4 mmol), potassium 
hydrogen sulphate (152 mg, 1.1 mmol) and methyl 2,4-
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pentadienoate (78) (1.5 g, 13.3 mmol) were heated together in a 
sealed tube at 150 °C for 24 h. After cooling the mixture was 
extracted with 2M hydrochloric acid (5 x 10 ml). The combined 
aqueous extracts were washed with diethyl ether (3 x 50 ml), 
basified with conc. ammonia and then extracted with 
dichloromethane (3 x 50 ml). The combined organic extracts were 
dried, filtered and evaporated under reduced pressure to give a 
brown oil which was purified by column chromatography on basic 
alumina and elution with ethyl acetate-methanol (95:1). The 
product (84) was obtained as a pale yellow oil (0.37 g, 26%); Rf 
0.59; vmax(CHCl3 ) 2940, 2810, 2760, 1710, 1645, 1445, 1270 and 
980 cm-l; 6H (200 MHz) (CDC13) 1.38-1.85 (4H, complex), 2.30-2.55 
(4H, complex), 2.77-3.08 (4H, complex), 3.70 (3H, s), 4.10 (1H, m) 
and 6.85 (1H, m); 8C(50 MHz) (CDCI3) 24.48 (t, C-8 ), 25.01 (t, C-7), 
26.48 (t, C-9), 28.68 (t, C-3), 48.85 (t, C-6 ), 51.37 ( q, C-12), 55.98 
(t, C-4), 60.29 (d, C-10), 133.71 (s, C -l), 137.24 (d, C-2) and 
166.95 (s, C -ll); m /z  196 (M++ 1), 195 (M+), 180, 166, 164, 136 
(100%), 106, 80, 53, 41, 28 and 18. (Found: M+ 195.1260. 
C11H17O2N requires 195.1259.)
Preparation of Methvl Ouinolizidine-l-carboxvlate (89)58
Methyl 1,2-didehydro-quinolizidine-l-carboxylate (84) 
(0.1 lg, 0.56 mmol) was added to a suspension of Adams1 catalyst 
( 10% w/w) in methanol (10 ml) and was hydrogenated at 1 
atmosphere for 12 h. The catalyst was filtered off through Florisil 
and the Florisil was washed well with methanol. Evaporation of 
the solvent under reduced pressure gave the product (89) (0.093 
g, 84%) which was purified (55%) by preparative TLC on silica gel
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and elution with CHCl3-MeOH-conc. ammonia (85:14:1), Rf 0.62; 
vm ax (CHCI3 ) 2950, 1730, 1620, 1435, 1270 and 1170 cnr*; 8H 
(200 MHz) (CDCI3) 1.38-1.65 (5H, complex), 1.70-2.20 (8H, 
complex), 2.58 (1H, m), 2.94 (2H, m) and 3.66 (3H, s); 8c (50 MHz) 
(CDCI3) 22.13 (t, C-3), 24.49 (t, C-8 ), 24.92 (t, C-7), 26.30 (t, C-9),
29.69 (t, C-2), 44.54 (d, O l) ,  51.25 (q, 0 1 2 ), 55.04 (t, 0 6 ), 57.16 
(t, 0 4 ) , 62.74 (d, 0 1 0 ) and 174.01 (s, O i l ) ;  m /z  197 (M %  182, 
166, 164, 136, 110, 106, 97, 83 (100%), 53, 41, 28 and 18. (Found: 
M + 197.1410. C11H19O2N requires 197.1416.)
Preparation of Luoinine (21)
Methyl quinolizidine-l-carboxylate (89) (0.06 g, 0.30 
mmol) in anhydrous diethyl ether (2 ml) was added dropwise to a 
stirred suspension of lithium aluminium hydride (0.40 g, 0.01 
mol) in anhydrous ether (4 ml) at room temperature under 
nitrogen. The mixture was stirred for 18 h then water (2.5 ml) 
was added at 0 °C and after 10 min potassium hydroxide (10% 
w /v, 2.5 ml) was added. The mixture was stirred for a further 30 
min then extracted with CH2Q2 (3 x 1 0  ml). The combined organic 
extracts were dried, filtered and concentrated to leave the product 
(21) as a pale yellow oil (0.04 g, 78%) which failed to solidify; Rf 
0.57; vmax (CHCI3 ) 3250, 2930, 1600, 1490 and 1145 cm-l; 8H 
(200 MHz) (CDCI3) 1.25 (2H, m), 1.55 (6H, m), 1.80 (3H, m), 2.09 
(2H, m), 2.81 (2H, m), 3.68 (2H, d, J 10 Hz, 11-H2), 4.13 (1H, m, 10- 
H) and 5.15 (1H, br s, -OH); 8C (50 MHz) (CDCI3) 22.93 (t, C-3), 
24.60 (t, C-8 ), 25.59 (t, C-7), 29.88 (t, C-9), 31.48 (t, C-2), 38.07 (d, 
C-l), 57.04 and 57.14 (2t, C-4 and -6 ), 65.08 (d, C-10) and 66.04 
(t, C-l 1); m /z  170 (M++ 1), 169 (M+), 168, 152, 138, 110, 98, 97,
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96, 83, 82, 55 and 41 (100%). (Found: M+ 169.1463. C10H19CN 
requires 169.1466.) The sample of lupinine (21) gave similar 
spectroscopic and chromatographic data to an authentic sample of 
lupinine and to literature values. H6
Preparation of Methvl 2.4-Hexadienoate (77)
2,4-Hexadienoic acid (11.2 g, 0.1 mol) in methanol (250 
ml) was stirred at 0 °C. Thionyl chloride (9 ml, 0.12 mol) was 
added and the solution was then allowed to warm to room 
temperature overnight. The solvent was then removed under 
reduced pressure leaving the product (77) as a pale yellow liquid 
which was purified by distillation (8.6 g, 68%); b.p. 160 °C (20 mm 
Hg); Rf0.63 (CHCI3); vmax (CHCI3) 3020, 2950, 1710, 1645, 1435, 
1330, 1275, 1250, 1145, 1000 and 870 cm*l; 6H (200 MHz) (CDCI3) 
1.75 (3H, d with fine splitting, J 5Hz, 6 -H3), 3.64 (3H, s), 5.70 (1H, 
d with fine splitting, J 15 Hz, 5-H), 5.98-6.20 (2H, complex, 2- and
4-H), 7.12-7.25 (1H, complex, 3-H); 8C (50 MHz) (CDCI3) 18.4 (q, C- 
6 ), 51.3 (q, -COCH3), 118.4 (d, C-2), 129.6 (d, C-5), 139.2 (d, C-4),
145.0 (d, C-3) and 192.2 (s, C-l); m /z  111 (M++ 1), 126 (M %  111, 
95, 67 (100%), 6 6 , 65, 51, 40, 39, 38, 31 and 29.
Preparation of 1.5-bis(N- PiperidvO-3-pentanone Dihvdrochloride
m )13
Piperidine hydrochloride (3.05 g, 25 mmol) and 
paraformaldehyde (0.75 g, 25 mmol) in glacial acetic acid (5 ml) 
were stirred at 98 °C Acetone (0.92 ml, 12.5 mmol) was added 
and the mixture was heated at reflux for 3 h. The solvent was
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then removed under reduced pressure and the residue was 
triturated with hot acetone (6 ml). The white solid formed was 
filtered off then triturated with hot chloroform (5 ml) and filtered 
again to leave the product (0.98 g, 24%). Evaporation of the 
mother liquors and trituration of the residue gave a further yield 
of product (0.12 g). Recrystallisation from methanol gave the 
product (91) as white crystals (0.10 g, 25%); m.p. 216-219 °C 
( l it,13 217-219 °C); Rf 0.63 [ethyl acetate-i-propanol-ammonia, 
(9:7:4)]; vmax (KBr disc) 2950, 2640, 1725, 1465, 1395, 1230, 
1105 and 1070 cm-l; 6H (200 MHz) (D20 ) 1.27 (4H, m), 1.37-1.78 
(8H, complex), 2.72 (4H, m), 2.91 (4H, t, 2- and 4-H2), 3.15 (4H, t,
1- and 5-H2) and 3.29 (4H, m); 6C (50 MHz) (D20) 21.60 (t, C-9 and 
-15), 23.57 (t, C-8 , -10, -14 and -16), 37.06 (t, C-2 and -4), 51.77 
(t, C-l and -5), 54.38 (t, C-7, -11, -13 and -17) and 206.90 (s, C-3); 
m /z  168, 167, 154, 136, 98 (100%), 85, 84, 70, 56, 55, 42, 41 and 
28.
Preparation of 8 -Ketosparteine (93)13
Freshly crystallised mercuric acetate (4.4 g, 13.9 mmol) 
was dissolved in aqueous acetic acid (5% v/v, 15 ml) at 95 °C
l,5-bis(N-Piperidyl)3-pentanone dihydrochloride (91) (0.50 g, 1.5 
mmol) was added and the mixture was heated at 95 °C for 2 h. A 
white precipitate was formed after 5 min. The mixture was then 
cooled, filtered and the precipitate was washed well with aqueous 
acetic acid. Hydrogen sulphide gas was bubbled through the 
filtrate until the solution was saturated and the mixture was then 
Filtered through Celite. This process was repeated until the 
solution no longer changed colour on treatment with hydrogen
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sulphide. The filtrate was then saturated with potassium 
carbonate and extracted with diethyl ether (3 x 50 ml). The 
combined organic extracts were dried, filtered and evaporated 
under reduced pressure to leave a yellow oil (0.11 g, 29%) which 
was found to be a mixture of seven products. The mixture was 
purified by column chromatography on basic alumina and elution 
with toluene-diethyl ether (5:1). 8 -Ketosparteine (93) was
obtained as a pale yellow semi-solid (0.020 g, 5%) which failed to 
solidify; RF 0.62; vmax (CHCI3 ) 3040, 2960, 1725, 1270, 1230 and 
1130 cm-l; 8H (200 MHz) (CDCI3) 1.05-1.67 (12H, complex), 1.95- 
2.10 (4H, complex), 2.31 (1H, dd, J  3 and 11 Hz), 2.45 (1H, m), 
2.63-2.98 (5H, complex) and 3.15 (1H, dd, J 5 and 10 Hz); 8C (50 
MHz) (CDCI3) 23.28 and 23.58 (2t, C-4 and -13), 25.37 and 25.48 
(2t, C-3 and -14), 29.83 (t, C-5), 34.88 (t, C-12), 51.86 (d, C-9), 
54.35 (t, C-17), 54.59 (d, C-7), 55.10 (t, C-15), 55.92 (t, C-2), 62.13 
(t, C-10), 66.63 and 66.75 (2d, C-6 and - 11 ) and 213.62 (s, C-8 ); 
m /z  249 (M++ 1), 248 (M ■*), 193, 150, 137, 110, 98 (100%), 84, 55, 
41 and 28. (Found: M+248.1879. C15H24CN2 requires 248.1888.)
Preparation of 1.5-bis(N- Hexahvdroazepinvl)-3-pentanone 
Dihvdrochloride (94)
This was prepared by the same method as l,5-bis(N- 
piperidyl)-3-pentanone dihydrochloride (91). The product (94) 
was obtained as a white solid (2.93 g, 66%), which was 
. reciystallised from methanol to give colourless crystals (0.96 g, 
22%); m.p 144-146 °C; Rp 0.71 (ethyl acetate-i-propanol-ammonia, 
9:7:4); v max (KBr disc) 2940, 2700, 1715, 1455, 1405, 1190, 1170 
and 1040 cm-l; 8H (200 MHz) (D20) 1.64 (8H, m), 1.82 (8H, m),
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3.05 (4H, t, 2- and 4-H2), 3.17 (4H, m), 3.34 (4H, t, 1- and 5-H?) 
and 3.40 (4H, m); 8C (50 MHz) (D20) 23.94 (t, C-9, -10, -16 and 
-17), 26.77 (t, C-8 , -11, -15 and -18), 38.09 (t, C-2 and -4), 52.33 
(t, C-l and -5), 55.74 (t, C-7, -12, -14 and -19) and 211.05 (s, C-3); 
m /z  169, 168, 140, 126, 112 (100%), 98, 84, 70, 58, 55, 42, 41 
and 28.
Attempted Oxidation of 1.5-bis(N-HexahvdroazepinvQ-3- 
pentanone Dihvdrochloride (94)_______
l,5-bis(N-hexahydroazepinyl)-3-pentanone 
dihydrochloride (94) (0.342 g, 0.98 mmol) was oxidised with 
mercuric acetate (2.82 g, 8.85 mmol) by the same method as 1,5- 
bis(N-piperidyl)-3-pentanone. Evaporation of the organic extracts 
gave a yellow viscous gum (0.101 g) which was found to be a 
mixture of 6  products. Column chromatography on basic alumina 
failed to isolate the desired product.
Attempted Preparation of 1.5-bis(N-PvrrolidvP-3-pentanone 
Dihvdrochloride
Pyrrolidine hydrochloride (0.54 g, 5 mmol) and 
paraformaldehyde (0.15 g, 5 mmol) in glacial acetic acid (1.5 ml) 
were stirred at 98 °C Acetone (0.2 ml, 2.7 mmol) was added and 
the mixture was heated at reflux for 3 h. The solvent was then 
removed under reduced pressure and the residue was triturated 
with diethyl ether (1.5 ml). The solvent was decanted off and the 
residue was triturated with chloroform (1 ml). The solvent was 
decanted off and the hydroscopic residue was found to be a
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mixture of products which could not be purified by trituration or 
recrystallisation.
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5.3 Experimental to Chapter 4
Spectrophotometric Assay105
The kinetic data of inhibition studies on diamine oxidase 
catalysed reactions were determined by the procedure of Stoner.* 
This involved a peroxidase coupled assay (horseradish peroxidase 
EC 1.11.1.7, from Sigma) to monitor the production of hydrogen 
peroxide from the oxidation reaction at 25 °C, 70 mM phosphate 
buffer (pH 6.3), and in the presence of 3-(dimethylamino)benzoic 
acid (DMAB) (113) and 3-methyl-2-benzothiazolinone hydrazone 
(MBTH) (112). This assay generates stoichiometric quantites of an 
indamine dye (114) with an absorbance maximum at 595 nm. 
The rates were measured directly in the spectrophotometer.
The solutions for the assay were prepared as follows;
Phosphate buffer 70 mM (sodium dihydrogen
phosphate 5.46 g/500 ml distilled 
water adjusted to pH 6.3 with 
disodium hydrogen phosphate 4.97 
g/500 ml distilled water)
MBTH (112) 0.6 mM (12.9 mg/100 ml distilled
water)
DMAB (113) 18 mM (59.4 m g/20 ml phosphate
buffer pH 6.3)
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Peroxidase 1.36 mg/4 ml phosphate buffer pH 
6.3
Pea seedling DAO 20/980^1 or 40/960jil phosphate
buffer pH 6.3 (ie. 1/50 or 1/25 
dilute)
The reaction was initiated by addition of the enzyme 
then inhibitor to the thermally equilibrated reaction medium, 
followed immediately by the substrate. The substrate was added 
last to minimise the possibility of extensive preincubation of the 
enzyme with the chromogenic agents producing additional 
inhibiting effects. The initial rates were measured from the linear 
absorbance changes during the first thirty seconds of reaction for 
a range of substrate concentrations. A separate experiment was 
carried out for each inhibitor concentration with every substrate 
concentration. A control experiment with no inhibitor present 
was also carried out before testing as kinetic data could vary 
slightly from day to day. Michaelis-Menten behaviour was 
observed in most cases. Rate data were analysed for Km  and Vmax 
by least squares fitting of Lineweaver-Burk (1 /V  vs 1/[S]) and 
Eadie-Hofstee (V vs V / [S]) plots. [See Appendix 1]
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General Procedure fo r N-A lkvlations10^
A solution of 4-chlorobutyronitrile or 5- 
chlorovaleronitrile in dry n -butanol (1 ml per 2 mmol of chloro- 
nitrile) was added to a mixture of pyrrolidine, piperidine or 
hexahydroazepine ( 1.1 equivalents), anhydrous sodium carbonate 
(1 equivalent) and a catalytic amount of potassium iodide (0.17 
equivalent), and was stirred at 105 °C for 18 h. Each solution was 
cooled and filtered through Celite. The filtered solid was washed 
well with diethyl ether, and the combined filtrate and washings 
were extracted with 4M hydrochloric acid (3 x 50 ml). The 
combined aqueous extracts were washed well with diethyl ether 
(2 x 100  ml), basified with solid sodium carbonate and extracted 
with diethyl ether (3 x 100 ml). The combined organic extracts 
were dried, filtered and concentrated under reduced pressure to 
give an oil which was purified by distillation.
N-(3-Cvanopropvl)pvrrolidine (149)
This was obtained as a clear oil (1.76 g, 60%); b.p. 40 °C 
(0.02 mm Hg); vmax (thin film) 2960 and 2240 cm-1; 8h (200 MHz) 
(CDCI3) 1.79 (6H, m) and 2.50 (8H, m); 8C(50 MHz) (CDCI3) 15.07 (t, 
C-7), 23.50 (t, C-3 and -4), 24.79 (t, C-8 ), 54.02 (t, C-2 and -5), 
54.45 (t, C-6 ) and 119.8 (t, C-9); m /z  138 (Af*), 137, 98, 84, 55, 41 
and 28 (100%). (Found: M+ 138.1155. C8Hi4N2 requires 
138.1156.)
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N - (3-Cvanopropvl)piperidine (151)
This was obtained as a clear oil (2.33 g, 64%); b.p. 30 °C 
(0.02 mm Hg); vmax (thin film) 2930 and 2240 cm*1; 6h (200 MHz) 
(CDCI3) 1.30-1.92 (8H, complex) and 2.33-2.44 (8H, m); 6C (50 
MHz) (CDCI3) 14.94 (t, C-8 ), 22.82 and 24.30 (2t, C-4 and -9), 25.88 
(t, C-3 and -5), 54.46 (t, C-2 and -6 ), 57.11 (t, C-7) and 119.7 (t, C- 
10); m /z  152 (M+), 98 (100%), 84, 55, 41 and 28. (Found: M+ 
152.1313. C9H16N2 requires 152.1313.)
N-(3-CvanopropvPhexahvdroazepine (153)
This was obtained as a clear oil (3.45 g, 87%); b.p. 55 °C 
(0.04 mm Hg); vmax (CHCI3 ) 2930 and 2240 cm-l; sH (200 MHz) 
(CDCI3) 1.48-1.65 (8H, complex), 1.74 (2H, tt, 9-H2), 2.40 (2H, t, J
7.5 Hz, IO-H2), 2.54 (2H, t, 77.5 Hz, 8 -H2) and 2.50-2.63 (4H,m, 2- 
and 7 -H2); 6C (50 MHz) (CDCI3) 14.84 (t, C-9), 23.80 (t, C-10), 26.91 
(t, C-4 and -5), 28.29 (t, C-3 and -6 ), 55.30 (t, C-2 and -7), 55.92 
(t, C-8 ) and 120.04 (t, C -ll);  m /z  166 (M+), 154, 141, 126, 112 
(100%), 98, 84, 55 and 41. (Found: M+ 166. C10H18N2 requires 
166.)
N-(4-CvanobutvDpyrrolidine (150)
This was obtained as a clear oil (4.25 g, 58%); b.p. 41 °C 
(0.18 mm Hg); vmax (thin film) 2960 and 2240 cm-1; 6h (200 MHz) 
(CDCI3) ; 6c (50 MHz) (CDCI3) 15.07 (t, C-7), 23.50 (t, C-3 and -4), 
24.79 (t, C-8 ), 54.02 (t, C-2 and -5), 54.45 (t, C-6 ) and 119.8 (t, C-
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9); m /z  152 (M+), 110, 84 (100%), 70, 55, 41 and 28. (Found: M+ 
152.1315. C9H16N2 requires 152.1313.)
JV-(4-Cvanobutvl)piperidine (152)
This was obtained as a clear oil (2.47 g, 62%); b.p. 45 °C 
(0.06 mm Hg); vmax (thin film) 2930 and 2240 cm-1; 8h (200 MHz) 
(CDCI3) 1.39-1.75 (10H, complex) and 2.35 (8H,m); 8C (50 MHz) 
(CDQ3) 16.25 (t, C-9), 22.87, 23.68 and 24.98 (3t, C-4, -8 and -10),
25.62 (t, C-3 and -5), 54.04 (t, C-2 and -6 ), 57.41 (t, C-7) and
119.5 (t, C-l 1); m /z  166 (M+), 98 (100%), 84, 55, 41 and 28. 
(Found: M + 166.1460. C10H18N2 requires 166.1469.)
N-(4-C vanobutvl Ihexahvdroazepine (154)
This was obtained as a clear oil (3.69 g, 85%); b.p. 60 °C 
(0.04 mm Hg); vmax (CHCI3 ) 2940 and 2260 cm-l; 6H (200 MHz) 
(CDCI3) 1.48-1.75 (12H, complex), 1.74 (2H, tt, 9 -H2), 2.35 (2H, t, J
7.5 Hz, I I -H 2), 2.45 (2H, t, J7.5 Hz, 8 -H2) and 2.51-2.63 (4H,m, 2- 
and 7-H2); 8C (50 MHz) (CDCI3) 16.99 (t, C-10), 23.37 (t, C-9), 26.51 
(t, C -ll) , 26.90 (t, C-4 and -5), 28.08 (t, C-3 and -6 ), 55.43 (t, C-2 
and -7), 56.96 (t, C-8 ) and 119.80 (t, C -l2); m /z  180 (AfO, 112 
(100%), 98, 84, 55 and 41. (Found: M+ 180.1622. C11H20N2 
requires 180.1626.)
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General Procedure fo r N itrile Reductions106
The N-alkylnitriles (149)-(154) were added to a 
suspension of Adams' catalyst (15% w/w) in glacial acetic acid (5 
ml per mmol of nitrile) and were hydrogenated at 1 atmosphere 
for 18 h. The catalyst was filtered off through Florisil and the 
Florisil was washed well with glacial acetic acid (25 ml). Cone, 
hydrochloric acid (10 ml) was added to the filtrates. Evaporation 
of the solvent under reduced pressure gave a solid which was 
recrystallised from 95% aqueous ethanol-acetone (1:1).
N-(4-Aminobutvl)pvrrolidinium Dihvdrochloride (115)
This was obtained as a white powder (1.52 g, 75%); m.p. 
206-208 °C (decomp.) (from 95% aq. EtOH-acetone, 1:1); vmax (KBr 
disc) 3130, 2980 and 1400 cm-1; 8h (200 MHz) (D2O with dioxan 
as reference at 3.53 ppm) 1.63 (4H, m, 7- and 8 -H2), 1.90 (4H, m,
3- and 4 -H2), 2.94 (4H, m, 2- and 5 -H2), 3.09 (2H, m, 9 -H2) and 
3.52 (2H, m, 6 -H2); 6c (50 MHz) (D2O with dioxan as reference at
67.4 ppm) 21.46, 23.47 and 23.65 (3t, C-3, -4, -7 and-8), 47.70 (t, 
C-9) and 54.95 (t, C-2, -5 and-6); m /z  142 (M+), 126, 84 (100%), 
55, 41 and 28.
N-(4-Aminobutvl)piperidinium dihvdrochloride (117)
This was obtained as a white powder (1.52 g, 67%); m.p. 
282-284 °C (decomp.) (from 95% aq. EtOH-acetone, 1:1); vmax (KBr 
disc) 3130, 2970 and 1405 cm*1; 5h (200 MHz) (D2O with dioxan 
as reference at 3.53 ppm) 1.67 (10H, m, 3-, 4-, 5-, 8- and 9 -H2),
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2.81 (2H, m, lO-hb), 2.99 (4H, m, 2- and 6 -H2) and 3.37 (2H, m, 7- 
Hz); 6c (50 MHz) (DzO with dioxan as reference at 67.4 ppm) 21.69,
22.02 and 23.74 (3t, C-3, -4, -5, -8 and -9), 47.75 (t, C-10), 54.11 
(t, C-2 and -6 ) and 56.87 (t, C-7); m /z  156 (M+), 126, 98 (100%), 
8 4 ,5 5 ,4 1 ,3 6  and 28.
/vM4-Aminobutvl)hexahvdroazepinium Dihvdrochloride (119)
This was obtained as a white powder (2.09 g, 86%); m.p. 
230-232 °C (decomp.) (from 95% aq. EtOH-acetone, 1:1); vmax (KBr 
disc) 3130, 2960 and 1400 cm-l; 6H (200 MHz) (D20  with dioxan 
as reference at 3.53 ppm) 1.17-1.69 (12H, complex, 3-, 4-, 5-, 6 -, 
9- and IO-H2), 2.79-3.05 (6H, complex, 2 -, 7-, 11-H2) and 3.27 
(2H, m, 8 -H2); 6c (50 MHz) (D2Owith dioxan as reference at 67.4 
ppm) 23.82 (t, C-10), 24.26 (t, C-4 and -5), 25.94 (t, C-9), 26.67 (t, 
C-3 and -6 ), 48.07 (t, C -ll) ,  55.53 (t, C-2 and -7) and 57.78 (t, C- 
8 ); m /z  170 (M+), 112 (100%), 98, 84, 55, 41 and 36.
N-(5-AminopentvPpyrrolidinium Dihvdrochloride (1161
This was obtained as a white solid (3.91 g, 85%); m.p. 
195-197 °C (decomp.) (from 95% aq. EtOH-acetone, 1:1); vmax (KBr 
disc) 3130, 2950, 1620 and 1455 cm-l; 6H (200 MHz) (D20) 1.12 
(2H, m, 8 -H2), 1.44 (4H, m, 7- and 9-H2), 1.59-1.83 (4H, m, 3- and
4-H2), 2.63-2.76 (4H, complex, 2- and 5-H2), 2.83 (2H, m, 10-H2) 
and 3.31 (2H, m, 6 -H2); 5c (50 MHz) (D20  with dioxan as reference 
at 67.4 ppm) 23.50, 23.67, 25.78 and 27.12 (4t, C-3, -4, -7, -8 and 
-9), 48.09 (t, C-10), 54.90 (t, C-2 and -5) and 55.47 (t, C-6 ).
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N-(5-AminopentvDpiperidinium Dihvdrochloride (118)
This was obtained as a white solid (3.06 g, 96%); m.p. 
192-193 °C (decomp.) (from 95% aq. EtOH-acetone, 1:1); vmax (KBr 
disc) 3130, 2945 and 1410 cm-1; 8h (200 MHz) (D2O with dioxan 
as reference at 3.53 ppm) 1.32 (4H, m, 9- and IO-H2), 1.65 (8H, m,
3-, 4-, 5- and 8 -H2), 2.80 (4H, m, 2 - and 6 -H2), 2.93 (2H, m, I I - H 2) 
and 3.40 (2H, m, 7 -H2); 8c (50 MHz) (D2O with dioxan as reference 
at 67.4 ppm) 21.29, 23.00, 23.14 and 25.17 (t, C-3, -4, -5, -8 , -9 
and -10), 47.32 (t, C -ll) , 53.34 (t, C-2 and -6 ) and 56.65 (t, C-7); 
m /z  170 (M-9, 140, 124, 98 (100%), 84, 70, 55, 41 and 36.
N-(5-Aminopentv0hexahvdroazepinium Dihvdrochloride (120)
This was obtained as a white powder (2.11 g, 82%); m.p. 
214-217 °C (decomp.) (from 95% aq. EtOH-acetone, 1:1); vmax (KBr 
disc) 2940 and 1470 cm-l; SH (200 MHz) (D2O) 1.46-1.75 (14H, 
complex, 3-, 4-, 5-, 6 -, 9-, 10- and I I - H 2), 2.70-3.05 (6H, complex,
2-, 7- and 12-H2) and 3.20-3.32 (2H, complex, 8-H2); 8C(50 MHz) 
(D2O with dioxan as reference at 67.4 ppm) 22.02 (t, C-4 and -5),
23.70 (t, C-10), 24.26 (t, C-3 and -6 ), 26.65 (t, C-9 and -11), 47.70 
(t, C-12), 55.59 (t, C-2 and -7) and 57.26 (t, C-8 ); m /z  184 (Af*), 
112 (100%), 98, 84, 55, 41 and 36.
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General Procedure for Mercury (11) Oxidations1(*>
Mercury (II) acetate (4 equivalents) was stirred in 5% 
aqueous acetic acid (6 ml/mmol of tertiary amine) at 120 °C until 
completely dissolved (ca. 2 min). To the solution was added the 
diamine dihydrochloride (1 equivalent) and the mixture was 
heated at 120 °C for 4 h. The reaction mixture was then cooled 
and filtered to remove precipitated mercury (I) salts. The filtrate 
was saturated with hydrogen sulphide gas, filtered through Celite, 
and the process was repeated. This removed mercury (II) salts. 
The aqueous solution was basified with 40% aqueous sodium 
hydroxide and was then extracted with chloroform (3 x 40 ml). 
The combined organic extracts were dried and filtered. Addition 
of dry hydrogen chloride gas precipitated the iminium salt. The 
solvent was decanted off and the residue was dried in vacuo. In 
each case a viscous yellow gum was obtained which did not 
solidify.
N-(4-Aminobutvn-l .2-didehvdropvrrolidinium Chloride 
Hydrochloride (54)
This was obtained as an oil 0.11 g, 46%; vmax (nujol 
mull) 2920, 2080 and 1625 cm-l; aH (200 MHz) (D20) 1.69-2.08 
(6 H, complex, 4-, 7- and 8 -H2), 2.26 (2H, m, 3-H2), 2.90-3.20 (4H, 
complex, 5- and 9-H2), 3.95 (2H, m, 6 -H2) and 8.65 (1H, br s, 2-H); 
8c (50 MHz) (D20) 19.3, 23.9 and 24.5 (3t, C-4, -7 and -8 ), 37.8 (t, 
C-3), 47.3 (t, C-9), 52.9 and 58,1 (2t, C-5 and -6 ) and 169.0 (s, C- 
2).
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N-(4-AminobutvD-l ,2-didehvdropiperid inium  Chloride
Hydrochloride (122)
This was obtained as an oil 0.24 g, 70%; vmax (nujol 
mull) 2910, 2020 and 1640 cnr*; 6H (200 MHz) (D2O) 1.41-1.85 
(8 H, complex, 4-, 5-, 8 - and 9-H?), 2.35 (2H, m, 3-H?), 2.70-3.03 
(4H, complex, 6 - and 10-H2), 3.58-3.85 (2H, complex, 7-H2) and 
8.50 (1H, br s, 2-H); 8C(50 MHz) (D20) 20.48, 23.66 and 25.04 (3t, 
C-4, -5, -8 and -9), 39.59 (t, C-3), 47.70 (t, C-10), 50.80 and 54.87 
(2t, C-6 and -7) and 170.03 (s, C-2).
N-(4-Aminobutvl)-l .2-didehvdrohexahvdroazepinium Chloride 
Hydrochloride
Addition of hydrogen chloride gas produced only 
starting material in 35% yield; 8h (90 MHz) (D20) noCH=N present.
JV-(5-Aminopentyl)-1.2-didehydropvrrolidinium Chloride 
Hydrochloride (121)
This was obtained as an oil 0.35 g, 58%; vmax (nujol 
mull) 2950, 2150 and 1640 cm-l; 8H (200 MHz) (D20 ) 1.21 (2H, m,
8 -H2), 1.41-1.89 (6H, complex, 4-, 7- and 9-H2), 2.28 (2H, m, 3- 
H2), 2.78-3.06 (4H, complex, 5- and 10-H2), 3.58-3.73 (2H, 
complex, 6 -H2) and 8.47 (1H, br s, 2-H); 6C(50 MHz) (D20 ) 20.02 (t, 
C-8 ), 23.43, 25.89 and 26.46 (3t, C-4, -7 and -9), 36.45 (t, C-3),
48.03 (t, C-10), 54.83 and 59.62 (2t, C-5 and -6 ) and 169.54 (s, C- 
2).
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N-(5-Am inopentvl)-l .2-didehvdropiperid inium  Chloride
Hydrochloride (123)
This was obtained as an oil 0.275 g, 57%; vmax (nujol 
mull) 2950, 2050 and 1645 cm-l; 8h (200 MHz) (DvO) 1.27 (4H, m,
9- and IO-H2), 1.38-2.05 (6H, complex, 4-, 5- and 8 -H2), 2.35 (2H, 
m, 3 -H2), 2.84 (4H, m, 6 - and I I - H 2), 3.58-3.70 (2H, complex, 7- 
H2) and 8.23 (1H, br s, 2-H); 6C (50 MHz) (D20) 20.42 (t, C-9), 
23.38, 23.64, 25.95 and 27.09 (4t, C-3, -4, -8 and -10), 39.98 (t, C-
3), 48.10 (t, C -ll) , 53.97 and 61.05 (2t, C-6 and -7) and 163.63 (s, 
C-2).
N-(5“Aminopentvl)-1.2-didehvdrohexahvdroazepinium Chloride 
Hydrochloride
Addition of hydrogen chloride gas produced only 
starting material in 29% yield; 8h (90 MHz) (D2O) no CH=N present.
Preparation of 1.5-bis(N-Piperidv0-3-pentanol (127)
l,5-bis(N-Piperidyl)3-pentanone dihydrochloride (91) 
(0.24 g, 0.73 mmol) in methanol (10 ml) was stirred at room 
temperature. Sodium borohydride (0.11 g, 2.92 mmol) was added 
over 2 h in small portions. The solvent was then removed under 
reduced pressure and the residue was triturated with CH2Q2 (20 
ml). Evaporation of the CH2CI2 gave the product (127) as a clear 
oil (0.187 g) in quantitative yield; Rp 0.66 [Ethyl acetate-i- 
propanol-ammonia, (9:7:4)]; vmax (CHCI3 ) 3150, 2920, 1460, 1435 
and 1115 cm-l; eH (200 MHz) (CDCI3) 1.32-1.73 (16H, complex),
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2.20-2.58 (12H, complex) and 3.77 (1H, m); 6C (50 MHz) (CDCI3) 
24.29 (t, C-9 and -15), 25.94 (t, C-8 , -10, -14 and -16), 33.29 (t, C- 
2 and -4), 54.61 (t, C-7, -11, -13 and -17), 57.33 (t, C-l and -5) 
and 72.95 (d, C-3); m /z  255 (M++ 1), 254 (M+), 170, 142, 98 
(100%), 84, 55, 41 and 28. (Found: M+ 254.2357. C15H30CN2
requires 254.2358.)
General Procedure for Preparation of trans-DiaminobuteneslQ8
Pyrrolidine, piperidine or hexahydroazepine (37.6 
mmol, 8 equivalents) was added over 15 min to a cooled solution 
of trans-l,4-dibromobut-2-ene (1.00 g, 4.68 mmol) in benzene (5 
ml). A white slurry was formed almost immediately in all three 
cases. In each case the solution was allowed to warm to room 
temperature, diluted with chloroform (40 ml) and then washed 
with water (40 ml). The organic layer was separated, dried (solid 
potassium carbonate) and filtered. The solvent was then removed 
under reduced pressure.
trans-1.4-bis-(N-Pvrrolidvl)but-2-ene
This was obtained as a pale yellow oil (0.75 g, 83%); Rp 
0.54 [ethyl acetate-i-propano 1-ammonia, (9:7:4)]; vmax (thin film) 
2960, 1675 (weak), 1345 and 970 cm**; 8H (200 MHz) (CDCI3) 1.78 
(8H, m), 2.50 (8H, m, 4 x CH2-N) 3.06 (4H, XzAA'X^ system, 1- and
4 -H2) and 5.71 (2H, X7AA,X?' system, 2- and 3-H); 8C (50 MHz) 
(CDCI3) 23.43 (t, 4 x CH2CH2N), 53.99 (t, 4 x O i2N), 58.00 (t, C-l 
and -4) and 130.37 (d, C-2 and -3); m /z  195 (M++ 1), 194 (M*0, 
124, 123, 110, 84 (100%), 55, 41 and 28.
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trans-L4-b is-(N -p iperidvl)but-2-ene
This was obtained as a white crystalline solid (1.00 g, 
96%); m.p. 49 °C; Rf 0.68 [ethyl acetate-i-propanol-ammonia, 
(9:7:4)]; vmax (KBr disc) 2930, 1300, 1130 and 970 cm-*; 8H (200 
MHz) (CDCI3) 1.38 (4H, m), 1.52-1.68 (8H, complex), 2.37 (8H, m, 4 
x CH2-N) 2.96 (4H, X2AA'X2' system, 1- and 4 -H2) and 5.67 (2H, 
X7AA,X?' system, 2- and 3-H); 8C (50 MHz) (CDCI3) 24.21 (t, 2 x 
CH2CH2CH2N), 25.79 (t, 4 x CH2CH2N), 54.39 (t, 4 x CH2N), 61.28 (t, 
C-l and -4) and 130.39 (d, C-2 and -3); m /z  222 (M+), 137 
(100%), 122, 98, 84, 55, 41 and 28.
trans-1.4-bis-( N-hexahvdroazepinvl)but-2-ene
The solvent was evaporated to leave a heterogeneous 
residue, which was triturated with diethyl ether. The solution 
was then evaporated to leave a pale yellow oil (1.05 g, 90%); Rf 
0.69 [ethyl acetate-i- propanol-ammonia, (9:7:4)]; vmax (thin film) 
2930, 1355 and 975 cm-l; 8H (200 MHz) (CDCI3) 1.52-1.74 (16H, 
complex), 2.58 (8H, m, 4 x CH2-N) 3.09 (4H, fc A A '^ ' system, 1- 
and 4 -H2) and 5.64 (2H, X7AA'X7' system, 2- and 3-H); 8c (50 MHz) 
(CDCI3) 26.79 (t, 4 x CH2CH2CH2N), 27.90 (t, 4 x CH2CH2N), 55.45 (t, 
4 x CH2N), 60.42 (t, C-l and -4) and 130.78 (d, C-2 and -3); m /z  
250 (M+), 151, 138, 136, 112 (100%), 98, 84, 55, 41 and 28.
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frans-1.4-bis-(N-Pvrrolidvl)but-2-ene D ihvdrochloride (128)
trans-l,4-bis-(/V-Pyrrolidyl)but-2-ene (0.50 g, 2.6 
mmol) was dissolved in diethyl ether (15 ml). An excess of 
diethyl ether saturated with dry hydrochloride gas was added to 
give a white precipitate. The solvent was decanted off and the 
product (128) (0.66 g, 96%) was dried in vacuo; m.p. 270 °C 
(decomp.). (Found: C, 53.74; H, 8.91; N, 10.30%. C12H24N2CI2
requires C, 53.93; H, 8.99; N, 10.49%.)
trans-1.4-bis-(AM?iperidvl)but-2-ene Dihvdrochloride (129)
trans-l,4-bis-(N-Piperidyl)but-2-ene (0.58 g, 2.61 
mmol) was dissolved in acetone (25 ml). 6M Hydrochloric acid 
was added dropwise to the solution, precipitating the product. 
The solid was Filtered off, washed well with acetone and then 
recrystallised from 95% aqueous ethanol-acetone (1:1). The 
product (129) was obtained as a white crystalline solid (0.75 g, 
97%). (Found: C, 57.19; H, 9.59; N, 9.40%. C14H28N2CI2 requires Q 
56.95; H, 9.49; N, 9.49%.)
trans-1.4-bis-(N-Hexahvdroazepinvl)but-2-ene Dihvdrochloride
1130)
This was prepared in the same way as trans-1,4-bis-(N- 
piperidyl)but-2-ene dihydrochloride. The product (130) was 
reciystallised from 95% aqueous ethanol-acetone (1:1) and was 
obtained as a white crystalline solid (0.77 g, 93%); m.p. 320 °C
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(decomp.). (Found: C, 59.30; H, 10.00; N, 8.58%. C16H32N2CI2
requires C, 59.44; H, 9.91; N, 8.67%.)
trans-N.Nl-bis(Cvclohexvl)-l .4-but-2-ene diamine 
Dihvdrobromide (131)
A solution of trans-1,4-dibromobut-2-ene (2.14 g, 0.01 
mol) in dichloromethane (15 ml) was added over 1 h to freshly 
distilled cyclohexylamine (1.98 g, 0.02 mol) in dichloromethane 
(30 ml) at room temperature. The solution was stirred for 18 h 
during which time a white precipitate appeared. The solid was 
filtered off and washed well with dichloromethane. 
Recrystallisation from methanol gave the product (131) as white 
crystals (1.04 g, 25%); m.p. 230 °C (decomp.); Rf 0.70 [ethyl 
acetate-i-propanol-ammonia, (9:7:4)]; vmax (KBr disc) 2940, 2550- 
2250, 1570, 1450 and 995 cm-1; 8H (200 MHz) (D2O) 0.88-1.31 
(10H, complex), 1.46 (2H, m), 1.65 (4H, m), 1.89 (4H, m),2.95 (2H, 
m, CH-N), 3.57 (4H, ^A A 'X ^  system, 1- and 4 -H2) and 5.85 (2H, 
X7AA,X?1 system, 2- and 3-H); 8c (50 MHz) (D2O with dioxan as 
reference at 67.4 ppm) 24.70 (t, 4 x CH2CH2CH-N), 25.28 (t, 
CH2CH2CH2CHNH), 29.67 (t, 4 x CH2CHNH), 45.78 (t, C-l and -4),
57.49 (d, 2 x CHNH) and 130.78 (d, C-2 and -3); m /z  207, 151 
(100%), 138, 136, 122, 112, 98, 81, 70, 56, 41 and 28. (Found: Q 
45.66; H, 7.31; N, 6.48%. Ci6H32N2Br2 requires C, 46.60; H, 7.77; N, 
6.80%.)
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Preparation o f cis-1.4-Dibromobut-2-ene (155)
cis-But-2-ene-l,4-diol (6.0 g, 0.068 mol) was added 
over 3 h to phosphorus tribromide (5 ml) with stirring at 0 °C 
The slowly warming solution was stirred for 15 h. Ice/water (25 
ml) was added slowly to hydrolyse excess phosphorus tribromide. 
The organic layer was separated, dissolved in diethyl ether (50 
ml) then washed with aqueous sodium bicarbonate (5%, 3 x 10 ml) 
and water (10 ml). The organic layer was dried, filtered and 
evaporated under reduced pressure to give a yellow oil (12.9 g, 
88%). Distillation gave a clear oil (12.4 g, 85%); b.p. 81 °C (14 
mmHg); vmax (thin film) 3040, 2970, 1450, 1390 1200 and 775 
cm-1; 6h (200 MHz) (CDCI3) 3.95 (4H, X2AA'X2' system, 1- and 4- 
H2) and 5.80 (2H, X?AA'X?' system, 2- and 3-H); m /z  213 (M~9, 
135, 133 (100%), 53, 39 and 28.
First Attempted Preparation of c j s -1  .4-bis-(/V-Piperidvl)but-2-ene 
i 1-3 31
Piperidine (3.8 ml, 37.6 mmol, 8 equivalents) was added 
over 15 min to a cooled solution of cis-l,4-dibromobut-2-ene 
(155) (1.00 g, 4.68 mmol) in benzene (5 ml). The solution was 
allowed to warm to room temperature, diluted with chloroform 
(40 ml) and then washed with water (40 ml). The organic layer 
was separated, dried (solid potassium carbonate) and filtered. 
The solvent was removed under reduced pressure to give a pale 
yellow oil. All spectral properties were identical to trans-1,4-bis- 
(N-piperidyl)but-2-ene (129).
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Second Attempted Preparation of ci's-1,4-bis-(N-Piperidvl)but-2- 
ene (133)
A solution of cis-l,4-dibromobut-2-ene (155) (2.14 g, 
0.01 mol) in dichloromethane (15 ml) was added over 1 h to 
freshly distilled piperidine (1.98 ml, 0.02 mol) in dichloromethane 
(30 ml) at room temperature. The solution was stirred for 18 h 
during which time a white precipitate appeared. The solid was 
filtered off and washed well with dichloromethane. All spectral 
properties were identical to tra n s - l,4-bis-(N-piperidyl)but-2-ene 
(129).
Third Attempted Preparation of c/s-l,4-bis-(AHPiperidv0but-2- 
ene (133)
Piperidine (3.8 ml, 37.6 mmol, 8 equivalents) was added 
over 15 min to a cooled solution of c/s-l,4-dichlorobut-2-ene 
(1.00 g, 4.68 mmol) in benzene (5 ml). The solution was allowed 
to warm to room temperature, diluted with chloroform (40 ml) 
and then washed with water (40 ml). The organic layer was 
separated, dried (solid potassium carbonate) and filtered. The 
solvent was removed under reduced pressure to give a pale 
yellow oil. All spectral properties were identical to trans-l ,4-bis- 
(N-piperidyl)but-2-ene (129).
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General Procedure fo r Alkene Reductions
Each trans-diaminoalkene dihydrochloride ( 128)-( 131) 
was added to a suspension of palladium on charcoal (20% w/w) in 
methanol (5 ml per mmol of alkene) and was hydrogenated at 1 
atmosphere for 2 h. The catalyst was filtered off through Celite 
and the Celite was washed well with methanol (25 ml). 
Evaporation of the filtrate under reduced pressure gave a solid 
which was recrystallised from 95% aqueous ethanol-acetone (1:1).
1.4-bis-(N-Pvrrolidvl)butane Dihvdrochloride (136)
This was obtained as a white solid (0.235 g, 88%); m.p. 
275 °C (decomp.)(from 95% aqueous ethanol-acetone, 1:1); Rf 0.31 
(CHQ3-methanol-ammonia, 90:9:1); vmax (KBr disc) 2940, 1630 
and 1450 cm~l; 6H (200 MHz) (D20) 1.67 (4H, m, 2- and 3-H2), 
1.82 (8H, m, 4 x CH2CH2-N), 2.97-3.10 (8H, complex, 4 x CH2-N) 
and 3.52 (4H, m, 1- and 4-H2); 8c (50 MHz) (D20  with dioxan as 
reference at 67.4 ppm) 23.50 (2t, 4 x CH2CH2-N and C-2 and -3) 
and 54.91 and 54.97 (2t, 4 x CH2-N and C-l and -4).
1.4-Bis-(N-piperidvl)butane Dihvdrochloride (137)
This was obtained as a white solid (0.264 g, 89%); m.p. 
315 °C (decomp.)(from 95% aqueous ethanol-acetone, 1:1); Rf 0.22 
(CHQ3-methanol-ammonia, 90:9:1); vmax (KBr disc) 2940, 1635 
and 1455 cm_1; 8h (200 MHz) (D20  with dioxan as reference at
3.53 ppm) 1.21-1.76 (16H, complex), 2.64-2.78 (4H, m), 2.88-2.95 
(4H, complex) and 3.30 (4H, m, 1- and 4-H2); 8c (50 MHz) (D20
143
with dioxan as reference at 67.4 ppm) 21.65 and 21.93 (2t, 2 x 
O bO bO b-N  and C-2 and -3), 23.64 (t, 4 x O bO b-N), 54.04 (t, 4 
xCFb-N) and 56.77 (t, C-l and -4); m /z  224 (Af*), 140, 124, 111, 
98 (100%), 84, 70, 55, 41 and 28. (Found: C, 56.65; H, *10.00; N, 
9.21%. C14H30N2CI2 requires C, 56.57; H, 10.10; N, 9.43%.)
1.4-bis-(JV-Hexahvdroazepinvl) butane dihydrochloride (138)
This was obtained as a white solid (0.276 g, 85%); m.p. 
285 °C (decomp.) (from 95% aqueous ethanol-acetone, 1:1); Rf 0.24 
(CHCl3-methanol-ammonia, 90:9:1); vmax (KBr disc) 2940, 1630 
and 1450 cm-1; 8n (200 MHz) (D2O with dioxan as reference at
3.53 ppm) 1.45-1.68 (20H, complex) and 2.95-3.30 (12H, 
complex); 8c (50 MHz) (DzOwith dioxan as reference at 67.4 ppm) 
22.02 (t, C-2 and -3), 24.24 (t, 4 x CH2CH2CH2-N ), 26.59 (t, 4 x 
CH2CH2-N), 55.60 (t, 4 x CH2-N) and 57.22 (t, C-l and -4); m /z  252 
(M-9, 209, 154, 112 (100%), 98, 84, 70, 55, 41 and 28.
A/.N'-Bislcvclohexvl)- 1.4-butane Diamine Dihvdrobromide (139)
This was obtained as a white solid (0.387 g, 94%); m.p. 
280 °C (decomp.) (from 95% aqueous ethanol-acetone, 1:1); Rf 0.29 
(CHCl3-methanol-ammonia, 90:9:1); vmax (KBr disc) 3430, 2935, 
2710-2250, 1630 and 1450 cm-l; 8H (200 MHz) (D2O with dioxan 
as reference at 3.53 ppm) 1.10 (10H, m), 1.53 (10H, m), 1.84 (4H, 
m), 2.88 (4H, m, 2- and 5 - H 2) and 3.51 (2H, m, CH-NH); 8C (50 
MHz) (D2O with dioxan as reference at 67.4 ppm) 23.95 (t, 2 x 
CH2CH2CH2CH-N), 24.75 (t, 4 x CH2CH2CH-N ), 25.33 (t, C-3 and -4),
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29.71 (t, 4 x CH2CH-N), 44.49 (t, C-2 and -5) and 58.06 (d, 2 x CH- 
N); m /z  153, 124, 110 (100%), 97, 84, 55, 41 and 28.
General Procedure for Preparation of Diaminobutvnes (141)- 
(1 4 3 )HQ
Piperidine, hexahydroazepine or cyclohexylamine (0.08 
mol, 4 equivalents) was added over 15 min at 0 °C to 1,4- 
dichlorobut-2-yne (2.46 g, 0.02 mmol). The solution was allowed 
to warm to room temperature over 1 h and diluted with water (30 
ml). The aqueous solution was then saturated with solid 
potassium carbonate and extracted with diethyl ether (3 x 10 ml). 
The combined organic extracts were dried, filtered and 
evaporated under reduced pressure to give an oil which was 
purified by distillation. The oil was then dissolved in acetone (35 
ml). 6M Hydrochloric acid was added dropwise to the solution, 
precipitating the product. The solid was filtered off, washed well 
with acetone and then recrystallised from 95% aqueous ethanol- 
acetone (1:1).
1.4-bis-(ft/-Piperidvl)but-2-vne Dihvdrochloride (141)
This was obtained as a white solid (5.49 g, 94%); m.p. 
275 °C (decomp.) (from 95% aqueous ethanol-acetone, 1:1); Rf 0.43 
(CHQ3-methanol-ammonia, 90:9:1); vmax (KBr disc) 2935, 2800, 
1450 and 1110 cm-1; 5h (200 MHz) (D2O with dioxan as reference 
at 3.53 ppm) 1.22-1.67 (12H, complex), 2.91 (4H, m), 3.47 (4H, m) 
and 3.98 (4H, s, 1- and 4-H2); 6c (50 MHz) (D2O with dioxan as 
reference at 67.4 ppm) 21.68 (t, GH2CH2CH2-N), 23.76 (t, 4 x
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CH2CH2-N), 46.72 (t, C-l and -4), 53.81 (t, 4 x CH2-N) and 79.65 (s, 
C-2 and -3); m /z  (free base) 220 (M*), 137, 136, 135, 134, 106, 
98 and 85 (100%). (Found: M+ 220.1937. C14H24N2 requires
220.1939.) (Found: C, 57.31; H, 9.23; N, 9.39%. C14H26N2CI2
requires C, 57.34; H, 9.56; N, 9.56%.)
1.4-bis-(/V-HexahvdroazepinvPbut-2-vne Dihvdrochloride (142)
This was obtained as a white solid (6.12 g, 95%); m.p. 
285 °C (decomp.) (from 95% aqueous ethanol-acetone, 1:1); Rf 0.48 
(CHCl3-methanol-ammonia, 90:9:1); vmax (KBr disc) 2910, 1450 
and 1315 cm-1; 8n (200 MHz) (D2O with dioxan as reference at
3.53 ppm) 1.54-1.78 (16H, complex), 3.17 (4H, m), 3.39 (4H, m) 
and 4.01 (411, m, 1- and 4 -H2); 6c (50 MHz) (D2O with dioxan as 
reference at 67.4 ppm) 24.63 (t, 2 x CH2CH2CH2-N), 26.30 (t, 4 x 
CH2CH2-N), 47.55 (t, C-l and -4), 55.89 (t, 4 x CH2-N) and 79.61 (s, 
C-2 and -3); m /z  (free base) 249 (M ++ 1), 248 (JVFO, 151, 150, 
149, 148, 134 and 99 (100%). (Found: M+ 248.2270. C16H28N2 
requires 248.2253.) (Found: C, 59.25; H, 9.46; N, 8.33%. 
C16H30N2CI2 requires C, 59.81; H, 9.35; N, 8.72%.)
N.N'-b'\s( C vclohexvO-1.4-bu t-2 -vne diamine Dihvdrobromide 
1143)
This was obtained as a white solid (6.10 g, 94%); m.p. 
240 °C (decomp.) (from 95% aqueous ethanol-acetone, 1:1); Rf 0.48 
(CHCl3-methanol-ammonia, 90:9:1); vmax (KBr disc) 3430, 2940, 
2780-2240, 1640 and 1500 cnrl; 5h (200 MHz) (D2O) 1.20 (12H, 
m), 1.55 (4H, m), 1.92 (4H, m), 3.12 (2H, m, CH-NH) and 3.89 (4H,
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s, 2- and 5-H2); 6c (50 MHz) (DvO) 24.73 (t, 4 x CH2CH2CH-N), 25.28 
(t, 2 x CH2CH2CH2CH-N), 29.54 (t, 4 x CH2CH-N), 34.32 (t, C-2 and 
-5), 57.45 (d, 2 xCH-N) and 79.15 (s, C-3 and -4); m /z  99, 70, 56 
(100%), 43, 36 and 28.
Preparation of 1.4-bis-(jV-Pvrrolidvl)but-2-vne Dihydrochloride
U 40)
Pyrrolidine (3.00 ml, 37.6 mmol, 8 equivalents) was 
added over 15 min to a cooled solution of l,4-dichlorobut-2-yne 
(0.58 g, 4.68 mmol) in benzene (5 ml). The solution was allowed 
to warm to room temperature, diluted with chloroform (40 ml) 
and washed with water (40 ml). The organic layer was separated, 
dried (solid potassium carbonate) and filtered. The solvent was 
removed under reduced pressure to give a yellow oil which was 
purified by distillation; b.p.95 °C (0.1 mm Hg) (lit.,HO 9 3 -950C, 0.1 
mm Hg). The oil was then dissolved in diethyl ether (15 ml). An 
excess of diethyl ether saturated with dry hydrochloride gas was 
added to give a white precipitate. The solvent was decanted off 
and the product was obtained as a white solid (1.22 g, 98%); m.p. 
235 °C (decomp.); Rf0.43 (CHCl3-methanol-ammonia, 90:9:1); vmax 
(KBr disc) 2960, 1630 and 1450 cm-l; 8H (200 MHz) (D20  with 
dioxan as reference at 3.53 ppm) 1.93 (8H, m), 3.08 (4H, m), 3.52 
(4H, m) and 4.04 (4H, s, 1- and 4-H2); 6C (50 MHz) (D20  with 
dioxan as reference at 67.4 ppm) 23.90 (t, 4 x CH2CH2-N), 44.06 (t,
. C-l and -4), 54.60 (t, 4 x CH2-N) and 79.20 (s, C-2 and -3); m /z  
(free base) 193 (M++ 1), 192 (AfO, 123, 122, 121, 120, 84 and 71 
(100%). (Found: M+ 192.1607. C12H20N2 requires 192.1626.)
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(Found: C, 54.53; H, 8.26; N, 9.74%. C12H22N2CI2 requires C, 54.34; 
H, 8.30; N, 10.57%.)
Preparation of 1.6-bis(N-Piperidvl)hexane Dihvdrobromide 
(144HH
Piperidine (3.48 ml, 34.8 mmol) was added to water (30 
ml) and 1,6-dibromohexane (1.34 ml, 8.7 mmol) was added with 
stirring. The mixture was heated at reflux for 6  h and then 
evaporated under reduced pressure to give a yellow solid which 
was recrystallised from methanol and acetone to give a white 
crystalline solid (1.82g, 51%); m.p. 280 °C; vmax (KBr disc) 2960, 
2940, 2640 and 1450 cm-l; 6h (200 MHz) (D2O) 1.08-1.65 (20H, 
complex) and 2.55-3.24 (12H, complex); 8c (50 MHz) (D2O with 
dioxan as reference at 67.4 ppm) 22.39 (t, 2 x CH2CH2CH2-N), 
24.05 (t, 4 x CH2CH2-N), 24.41 (t, C-3 and -4), 26.52 (t, C-2 and -5), 
54.31 (t, 4 x CH2-N) and 57.93 (t, C-l and -6 ); m /z  252 (M +), 123, 
168, 154, 98 (100%) and 84. (Found: C, 46.16; H, 8.30; N, 6.63%. 
Cl6H34N2Br2 requires C, 46.38; H, 8.21; N, 6.76%.)
Preparation of Methvl pipecolate Hydrochloride (156)
To a suspension of pipecolic acid (4.0 g, 0.031 mol) in 
anhydrous 2 ,2 -dimethoxypropane (60 ml) stirred while heated at 
reflux was added conc. hydrochloric acid (17.6 ml). Once all the 
acid had dissolved (ca. 20  min), the solution was cooled and was 
then stirred at room temperature for 72 h. Evaporation of the 
solvent at 35 °C gave a dark brown solid (6.3 g). Recrystallisation 
from methanol and ether gave the product as a white solid (5.3 g,
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96%); m.p 144-146 °C; Rp 0.70 [ethyl acetate-i-propanol-ammonia, 
(9:7:4)]; vmax (KBr disc) 3440, 2920, 2800, 2720, 1750, 1580, 
1280, 1230 and 1030 cm-l; 8H (200 MHz) (D?0) 1.42-1.73 (5H, 
complex), 2.10 (1H, m), 2.86 (1H, m), 2.29 (1H, m), 3.64 (3H, s) and 
3.87 (1H, dd, J 4 and 11 Hz); 8C(50 MHz) (D20) 22.34 and 22.46 (t, 
C-3 and -4), 26.71 (t, C-5), 45.20 (t, C-2), 54 70 (q, C-8 ), 57.86 (d, 
C-6 ) and 171.27 (s, C-7); m /z  143 (M +), 84 (100%), 82, 56, 41 and
28.
Preparation of Methvl 1.6-bis(N- Pipecolate)hexane (146)
Methyl pipecolate hydrochloride (156) (0.905 g, 5 
mmol) in anhydrous benzene (6 ml) was stirred overnight with 
triethylamine (0.7 ml, 5 mmol) at room temperature. The mixture 
was filtered and the filtrate was added over 90 min to 1,6- 
dibromohexane in anhydrous benzene (6 ml) under nitrogen at 70 
°C. The reaction flask also contained anhydrous potassium 
carbonate (2.16 g, 15.6 mmol) and potassium iodide (0.16 g, 0.96 
mmol). The mixture was stirred at 70 °C for 4 d, cooled, then 
poured into water (15 ml). The aqueous layer was separated then 
extracted with diethyl ether (3 x 25 ml). The organic extracts 
were extracted with 1M phosphoric acid (3 x 50 ml). The 
combined acidic extracts were saturated with potassium carbonate 
and then extracted with CH2Q2 (5 x 150 ml). The combined 
organic extracts were dried, filtered and evaporated under 
reduced pressure to leave a yellow oil (0.545 g, 59%). The product 
(146) was purified (19%) by column chromatography on basic 
alumina and elution with pentane-toluene (2 :1 ); Rf 0.67; vmax 
(CHQ3 ) 2940, 1735, 1440, 1190 and 1160 cm-l; 6H (200 MHz)
149
(CDCls) 1.20-1.95 (16H, complex), 2.15-2.62 (811, complex), 3.20 
(6 H, m) and 3.73 (6H, s); 8C(50 MHz) (CDCI3) 22.43 (t, C-3 and -4), 
25.00 (t, C-10 and -16), 26.23 (t, C-2 and -5), 27.37 (t, C-9 and 
-15), 29.39 (t, C - ll  and -17), 50.59 (t, C-l and -6 ), 51.75 (q, C-20 
and -22), 56.60 (t, C-12 and -18), 65.11 (t, C-8 and -14) and
173.84 (s, C-19 and -21); m /z  369 (M++ 1), 368 (M+), 353, 309 
(100%), 291, 166, 128, 110, 98, 84, 55, 41 and 28. (Found: M+ 
368.2683. C20H36C4N2 requires 368.2675.)
Preparation of 1,6 -bis(N-Pipecolic acid)hexane (157)
Methyl l , 6 -bis(N-pipecolate)hexane (146) (0.088 g, 0.23 
mmol) in 4M hydrochloric acid was heated at reflux for 48 h. The 
solvent was then removed under reduced pressure to leave a 
clear oil (0.098 g, 99%); v max (CHCI3 ) 3200-2400, 2940, 1735, 
1450, 1380, 1280, 1210 and 1050 cm-l; 8H (200 MHz) (CDCI3) 1.17 
(4H, m), 1.35-2.00 (16H, complex), 2.06 (2H, m), 2.75-3.13 (6H, 
complex), 3.51 (2H, m) and 3.78 (2H, dd, J  4 and 11 Hz); 8C (50 
MHz) (CDCI3) 21.51 (t, C-3 and -4), 22.75 (t, C-10 and -16), 24.02 
(t, C-2 and -5), 25.94 (t, C-9 and -15), 28.29 (t, C - l l  and -17), 
52.78 (t, C-l and -6 ), 57.02 (t, C-12 and -18), 65.88 (t, C-8 and 
-14) and 172.30 (s, C-19 and -21); m /z  248, 246, 202 (100%), 
114, 98, 84, 55,41 and 28.
Oxidation of 1.6-bis(N-Pipecolic acid)hexane (145)
l , 6 -bis(JV-Pipecolic acid)hexane (157) (0.058 g, 0.14 
mmol) and phosphorus oxychloride (0.22 g, 1.44 mmol) were 
heated together at 100 °C for 3 min. The solution was cooled and
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ice/water (10 ml) was added carefully. Evaporation of the solvent 
gave a clear oil which was taken up in deionised water and passed 
down an Amberlite IRA-400 ion-exchange column (in the chloride 
form). The elutate was concentrated to give the product (145) as 
a clear oil (0.21 g); vmax (thin film) 2950, 2320, 1680 and 1000 
cm-l; 8h (200 MHz) (CDCI3) 1.28 (4H, m), 1.46-2.00 (12H, complex), 
3.77 (4H, m), 3.53-3.82 (8H, complex) and 8.45 (2H, br s); 6C (50 
MHz) (CDCI3) 21.09 (t, C-3, -4, -10 and -16), 25.91 (t, C-2, -5, -11 
and -17), 27.14 (t, C-9 and -15), 51.53 (t, C-l and -6 ), 62.97 (t, C- 
12 and -18), 179.82 (t, C-8 and -14).
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A p pe nd ix  1
Spectrophotometric Assay
Calculation of Results for Cadaverine as a Substrate of DAO 
Assay: 2500 jil Phosphate buffer pH 6.3
170pl DMAB
lOOjil MBTH
50ja1 Peroxidase
25jil Pea seedling DAO (1 /50 dilute)
300^1 Cadaverine (range of concentrations)
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Substrate Concentrations and Rates
Substrate Rate Rate
Concentration (mM) (conc/sec x 10 ' 7) (nmol/mg/hr)
0.92 3.10 3018
0.74 2.88 2804
0.55 2.87 2794
0.37 2.55 2482
0.18 2.10 2044
0.092 1.46 1421
0.074 1.28 1246
0.055 1.06 1032
0.037 0.81 789
0.018 0.42 409
Results from Lineweaver Burk and Eadie Hofstee Plots.
Km  (mM) V max (nmol/mg/hr)
Lineweaver Burk 0.13 3514
Plot
Eadie Hofstee 0.13 3388
Plot
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Inh ib ition o f Diamine Oxidase
Calculation of Results for N-(5-Aminopentyl)hexahydroazepinium 
dihydrochloride (120) as an Inhibitor of DAO with Cadaverine as a 
Substrate.
Assay: 2500 jil Phosphate buffer pH 6.3
170^1 DMAB
lOOixl MBTH
50^1 Peroxidase
25jil Pea seedling DAO (1/50 dilute)
300^1 Cadaverine (range of concentrations)
lOOfil N-(5-Aminopentyl)hexahydro-
azepinium dihydrochloride (1 2 0 ) 
(inhibitor)
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Substrate Concentrations and Rates w ith Inh ib ito r Concentration
o f 0 mM.
Substrate Rate Rate
Concentration (mM) (cone/sec x 10“7) (nmo 1/m g/hr)
0.93 3.75 3650
0.74 3.55 3456
0.56 3.43 3339
0.37 3.46 3368
0.19 2.75 2677
0.093 1.64 1597
0.074 1.61 1567
0.056 1.12 1090
0.037 0.91 886
0.019 0.39 380
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Substrate Concentrations and Rates w ith  Inh ib ito r Concentration
o f 1 mM.
Substrate Rate Rate
Concentration (mM) (conc/sec x 10"7) (fimol/mg/hr)
0.93 2.50 2434
0.74 2.40 2336
0.56 2.29 2229
0.37 1.86 1811
0.19 1.14 1110
0.093 0.67 652
0.074 0.53 516
0.056 0.42 409
0.037 0.28 272
0.019 0.15 146
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Substrate Concentrations and Rates w ith Inh ib ito r Concentration
o f 0.5 mM.
Substrate Rate Rate
Concentration (mM) (conc/sec x 10 ' 7) (nmol/mg/hr)
0.93 3.33 3242
0.74 3.14 3057
0.56 2.91 2833
0.37 2.46 2395
0.19 1.48 1440
0.093 0.90 876
0.074 0.77 750
0.056 0.59 574
0.037 0.39 380
0.019 0.21 204
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Substrate Concentrations and Rates w ith Inh ib itor Concentration
o f 0.25 mM.
Substrate
Concentration (mM)
0.93
0.74
0.56
0.37
0.19
0.093
0.074
0.056
0.037
0.019
Rate
(conc/sec x 10"7)
3.49
3.54 
3.19
2.84 
2.00
1.16 
0.98 
0.80 
0.52
0.29
Rate
(fimol/mg/hr)
3398
3446
3105
2765
1947
1129
954
779
506
282
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Inhibition of Diamine Oxidase activity 
by N-(5-Aminopentyl)hexamethylene imine.
[I]= lm M7
6
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1
0
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